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Abstract
In this paper, we derive and analyse a model for the control of arboviral diseases which takes
into account an imperfect vaccine combined with some other mechanisms of control already studied
in the literature. We begin by analyse the basic model without controls. We prove the existence of
two disease-free equilibrium points and the possible existence of up to two endemic equilibrium points
(where the disease persists in the population). We show the existence of a transcritical bifurcation
and a possible saddle-node bifurcation and explicitly derive threshold conditions for both, including
defining the basic reproduction number, R0, which determines whether the disease can persist in the
population or not. The epidemiological consequence of saddle-node bifurcation (backward bifurcation)
is that the classical requirement of having the reproduction number less than unity, while necessary,
is no longer sufficient for disease elimination from the population. It is further shown that in the
absence of disease–induced death, the model does not exhibit this phenomenon. We perform the sen-
sitivity analysis to determine the model robustness to parameter values. That is to help us to know
the parameters that are most influential in determining disease dynamics. The model is extended by
reformulating the model as an optimal control problem, with the use of five time dependent controls,
to assess the impact of vaccination combined with treatment, individual protection and vector control
strategies (killing adult vectors, reduction of eggs and larvae). By using optimal control theory, we
establish optimal conditions under which the disease can be eradicated and we examine the impact of
a possible combined control tools on the disease transmission. The Pontryagin’s maximum principle
is used to characterize the optimal control. Numerical simulations, efficiency analysis and cost effec-
tiveness analysis show that, vaccination combined with other control mechanisms, would reduce the
spread of the disease appreciably, and this at low cost.
Keywords: Arboviral diseases; Bifurcation; Sensitivity analysis; Optimal control; Pontryagin’s
Maximum Principle; Efficiency analysis, Cost effectiveness analysis.
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1 Introduction
Arboviral diseases are affections transmitted by hematophagous arthropods. There are cur-
rently 534 viruses registered in the International Catalog of Arboviruses and 25% of them
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have caused documented illness in human populations [15, 35, 30]. Examples of those kinds of
diseases are Dengue, Yellow fever, Saint Louis fever, Encephalitis, West Nile fever and Chikun-
gunya. A wide range of arboviral diseases are transmitted by mosquito bites and constitute
a public health emergency of international concern. For example, Dengue, caused by any of
four closely-related virus serotypes (DEN-1-4) of the genus Flavivirus, causes 50–100 million
infections worldwide every year, and the majority of patients worldwide are children aged 9 to
16 years [53, 65, 64].
The dynamics of arboviral diseases like Dengue or Chikungunya are influenced by many
factors such as human and mosquito behaviours. The virus itself (multiple serotypes of dengue
virus [65, 64], and multiple strains of chikungunya virus [22, 46]), as well as the environment,
affects directly or indirectly all the present mechanisms of control [5, 13]. Indeed, in the
absence of conditions which favour the development of their larvae, eggs of certain Aedes
mosquitoes (Aedes albopictus, for example) enter in diapause phenomenon, allowing the eggs
to hatch even after two years [47, 57]. Taking the case of Aedes mosquitoes for example,
the main control method used in many countries continues to be space spraying of insecticide
for adult mosquito control. This strategy must be repeated constantly, its cost is high, and
its effectiveness is limited. Also, Ae. aegypti, for example, prefers to rest inside houses, so
truck or aerial insecticide spraying simply does not reach mosquitoes resting in hidden places
such as cupboards [63]. The different types of control mechanisms put in place to reduce the
proliferation of vectors responsible for the transmission of pathogens such as arboviruses are
listed below..
(i) Biological control or ”biocontrol” is the use of natural enemies to manage vector popula-
tions: introduction of parasites, pathogens and predators to target vectors. for example,
effective biocontrol agents include predatory fish that feed on mosquito larvae such as
mosquitofish (Gambusia affinis) and some cyprinids (carps and minnows) and killifish.
Tilapia also consume mosquito larvae [11]. As biological control does not cause chemi-
cal pollution, it is considered as a better method for mosquito control by many people.
However, there are limitations on employing biological agents for mosquito control. The
agent introduced usually has to be substantial in number for giving desirable effect.
(ii) Mechanical control consist at the environmental sanitation measures to reduce mosquito
breeding sites, such as the physical management of water containers (e.g. mosquito-proof
covers for water storage containers, polystyrene beads in water tanks), better designed
and reliable water supplies, and recycling of solid waste such as discarded tyres, bottles,
and cans [63, 23].
(iii) Chemical methods [63, 23]:
– chemical methods against the mosquito’s aquatic stages for use in water containers
(larviciding –killing of larvae),
– chemical methods directed against adult mosquitoes, such as insecticide space sprays
or residual applications (adulticiding –killing of adult mosquitoes),.
(iv) Personal protection consist at the use of repellents, vaporizers, mosquito coils, and insec-
ticide treated screens, curtains, and bednets (for daytime use against Aedes) [63].
The main problem encountered in the implementation of some of these control mechanisms
is the preservation of the ecological systems. For example, in the ”biocontrol” mechanism,
direct introduction of tilapia and mosquitofish into ecosystems around the world have had
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disastrous consequences [11]. Also, the chemical methods can not be applied in continuous
times. Some chemical product like Deltamethrin seems to be effective only during a couple of
hours [23, 8, 33]. So its use over a long period and continuously, leads to strong resistance of
the wild populations of Aedes aegypti [19], for example.
For all the diseases mentioned above, only yellow fever has a licensed vaccine. Nevertheless,
considerable efforts are made to obtain vaccines for other diseases. In the case of dengue, for
example, tests carried out in Asia and Latin America, have shown that the future dengue vaccine
will have a efficacy between 30.2% and 77.7%, and this, depending on the serotype [51, 60].
Also, the future dengue vaccine will have an overall efficacy of 60.8% against all forms of the
disease in children and adolescents aged 9-16 years who received three doses of the vaccine[54].
As the future vaccines (e.g., dengue vaccine) will be imperfect, it is therefore necessary to
combine such vaccines with some control mechanisms cited above, to find the best sufficient
combination (in terms of efficacy and costs), which permit to decrease the expansion of these
kind of diseases in human communities.
A number of studies have been conducted to study host-vector models for arboviral diseases
transmission (see [23, 1, 2, 4, 6, 7, 10, 16, 18, 20, 25, 26, 27, 29, 41, 43, 44, 48, 50]). Some
of these works have been conducted to explore optimal control theory for arboviral disease
models (see [4, 7, 44, 50, 62]).
In [4], Dipo Aldila and co-workers derive a optimal control problem for a host-vector Dengue
transmission model, in which treatments with mosquito repellent are given to adults and chil-
dren and those who undergo treatment are classified in treated compartments. The only control
considered by the authors is the treatment of people with clinical signs of the disease. Blayneh
et al. in [7] consider a deterministic model for the transmission dynamics of West Nile virus
(WNV) in the mosquito-bird-human zoonotic cycle. They use two control functions, one for
mosquito-reduction strategies and the other for personal (human) protection, and redefining
the demographic parameters as density-dependent rates. In [44], Moulay et al. derive optimal
prevention (individual protection), vector control (Larvae reduction) and treatment strategies
used during the Chikungunya Re´union Island epidemic in 2006. Authors in [50] derive the op-
timal control efforts for vaccination in order to prevent the spread of a Dengue disease using a
system of ordinary differential equations (ODEs) for the host and vector populations. Recently,
Dias et al. in [62] analyse the Dengue vector control problem in a multiobjective optimization
approach, in which the intention is to minimize both social and economic costs, using a dynamic
mathematical model representing the mosquitoes’ population. This multiobjective optimization
approach consists in finding optimal alternated step-size control policies combining chemical
(via application of insecticides) and biological control (via insertion of sterile males produced
by irradiation).
None of the above mentioned models [4, 7, 44, 50, 62] takes into account the combination
of optimal control mechanisms such as vaccination, individual protection, treatment and vector
control strategies. In our effort, we investigate such optimal strategies for vaccination combined
with individual protection, treatment and two vector controls (adulticiding–killing of adult
vectors, and larviciding–killing eggs and larvae), using two systems of ODEs which consist of
a complete stage structured model Eggs-Larvae-Pupae for the vectors, and a SEI/SEIR type
model for the vector/host population. This provides a new different mathematical perspective
to the subject. Furthermore, a efficiency analysis and cost effectiveness analysis, are performed
here in order to evaluate the control combination that is most effective in the design of optimal
strategies.
We start with the formulation of a model without control which is an modified of the
previous models developed in [1, 2]. We compute the net reproductive number N , as well as
the basic reproduction number, R0, and investigate the existence and stability of equilibria.
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We prove that the trivial equilibrium is globally asymptotically stable whenever N < 1. When
N > 1 and R0 < 1, we prove that the system exhibit the backward bifurcation phenomenon.
The implication of this occurrence is that the classical epidemiological requirement for effective
eradication of the disease, R0 < 1, is no longer sufficient, even though necessary. We show
the existence of a transcritical bifurcation and a possible saddle-node bifurcation and explicitly
derive threshold conditions for both.
Then, we formulate an optimal control model by adding five control functions: three for
human (vaccination, protection against mosquitoes bites and treatment), and two for mosquito-
reduction strategies (the use of adulticide to kill adult vectors, and the use of larvicide to in-
crease the mortality rate of eggs and larvae). By Using optimal control theory, we derive the
conditions under which it is optimal to eradicate the disease and examine the impact of a pos-
sible combination of vaccination, treatment, individual protection and vector control strategies
on the disease transmission. The Pontryagin’s maximum principle is used to characterize the
optimal control. Numerical simulations, efficiency analysis, as well as, the cost effectiveness
analysis, are performed to determine the best combination (in terms of efficacy and cost).
The rest of the paper is organized as follows. In section 2, we present the basic transmission
model and carry out some analysis by determining important thresholds such as the net repro-
ductive number N and the basic reproduction number R0, and different equilibria of the model.
We then demonstrate the stability of equilibria and carry out bifurcation analysis, by deriv-
ing the threshold conditions for saddle–node bifurcation. In Section 3 we present the optimal
control problem and its mathematical analysis. Section 4 is devoted to numerical simulations,
efficiency analysis and cost effectiveness analysis. A conclusion round up the paper.
2 The basic model and its analysis
The model we propose here is based on the modelling approach given in [1, 2]. For the reader
convenience, we briefly recall here main results which are developed in this work.
It is assumed that the human and vector populations are divided into compartments de-
scribed by time–dependent state variables. The compartments in which the populations are
divided are the following ones:
(i) For humans, we consider a SEIR model: Susceptible (denoted by Sh), exposed (Eh),
infectious (Ih) and resistant or immune (Rh) which includes naturally-immune individuals. The
recruitment in human population is at the constant rate Λh, and newly recruited individuals
enter the susceptible compartment Sh. Are concern by recruitment people that are totally naive
from the disease. Each human compartment, individual goes out from the dynamics at natural
mortality rates µh. The human susceptible population is decreased following infection, which
can be acquired via effective contact with an exposed or infectious vector at a rate
λh =
aβhv(ηvEv + Iv)
Nh
, (1)
where a is the biting rate per susceptible vector, βhv is the transmission probability from an
exposed/infectious vector (Ev or Iv) to a susceptible human (Sh). The expression of λh is
obtained as follows. The probability that a vector chooses a particular human or other source
of blood to bite can be assumed as
1
Nh
. Thus, a human receives in average a
Nv
Nh
bites per
unit of times. Then, the infection rate per susceptible human is given aβhv
Nv
Nh
(ηvEv + Iv)
Nv
. In
expression of λh, the modification parameter 0 < ηv < 1 accounts for the assumed reduction
in transmissibility of exposed mosquitoes relative to infectious mosquitoes [1, 2, 29] (see the
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references therein for the specific sources). Latent humans (Eh) become infectious (Ih) at rate
γh. Infectious humans recover at a constant rate, σ or dies as consequence of infection, at a
disease-induced death rate δ. Immune humans retain their immunity for life. We denote the
total human population by Nh,
Nh = Sh + Eh + Ih +Rh. (2)
(ii) Following [43], the stage structured model is used to describe the vector population
dynamics, which consists of three main stages: embryonic (E), larvae (L) and pupae (P). Even
if eggs (E) and immature stages (L and P) are both aquatic, it is important to dissociate them
because, for optimal control point of view, drying the breeding sites does not kill eggs, but only
larvae and pupae. Moreover, chemical interventions on the breeding sites have a more great
impact on the larval population, but not on the eggs [43]. The number of laid eggs is assumed
proportional to the number of females. The system of stage structured model of aquatic phase
development of vector is given by (see [43] for details)
E˙ = µb
(
1− E
ΓE
)
(Sv + Ev + Iv)− (s+ µE)E (3a)
L˙ = sE
(
1− L
ΓL
)
− (l + µL)L (3b)
P˙ = lL− (θ + µP )P. (3c)
Unlike the authors of [43], we take into account the pupal stage in the development of the
vector. This is justified by the fact that they do not feed during this transitional stage of
development, as they transform from larvae to adults. So, the control mechanisms can not be
applied to them.
With a rate θ, pupae become female adults. Each vector compartment, individuals goes
out from the dynamics at natural mortality rates µv. The vector susceptible population is
decreased following infection, which can be acquired via effective contact with an exposed or
infectious human at a rate
λv =
aβvh(ηhEh + Ih)
Nh
, (4)
where βvh is the transmission probability from an exposed/infectious human (Eh or Ih) to
a susceptible vector (Sv). As well as in the expression of λh, the modification parameter
0 < ηh < 1 in the expression of λv accounts for the assumed reduction in transmissibility of
exposed humans relative to infectious humans [1, 2, 29]. Latent vectors (Ev) become infectious
(Iv) at rate γv. The vector population does not have an immune class, since it is assumed
that their infectious period ends with their death [26]. So, we denote the total adult vector
population by Nv,
Nv = Sv + Ev + Iv. (5)
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Figure 1: Schematic of the vector-borne epidemic model with development stage of vectors.
Therefore, our basic arboviral disease model reads as
S˙h = Λh − (λh + µh)Sh (6a)
E˙h = λhSh − (µh + γh)Eh (6b)
I˙h = γhEh − [µh + δ + σ] Ih (6c)
R˙h = σIh − µhRh (6d)
S˙v = θP − λvSv − µvSv (6e)
E˙v = λvSv − (µv + γv)Ev (6f)
I˙v = γvEv − (µv)Iv (6g)
E˙ = µb
(
1− E
ΓE
)
Nv − (s+ µE)E (6h)
L˙ = sE
(
1− L
ΓL
)
− (l + µL)L (6i)
P˙ = lL− (θ + µP )P (6j)
where the upper dot denotes the time derivative and λh and λv are given by (1) and (4),
respectively. A schematic of the model is shown in Figure 1. The states and parameters are all
strictly positive constants and are described in Table 1 and 2, respectively.
Table 1: The state variables of model (6).
Humans Aquatic Vectors Adult Vectors
Sh: Susceptible E: Eggs Sv: Susceptible
Eh: Infected in latent stage L: Larvae Ev Infected in latent stage
Ih: Infectious P : Pupae Iv Infectious
Rh: Resistant (immune)
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Table 2: Description and baseline values/range of parameters of model (6). The baseline values
refer to dengue fever transmission.
Parameter Description Baseline Sources
value/range
Λh Recruitment rate of humans 2.5 day
−1 [29]
µh Natural mortality rate in humans
1
(67×365)
day−1 [29]
a Average number of bites 1 day−1 [4, 29]
βhv Probability of transmission of 0.1, 0.75 day
−1 [4, 29]
infection from an infected vector
to a susceptible human
γh Progression rate from Eh to Ih
[
1
15
, 1
3
]
day−1 [23, 55]
δ Disease–induced death rate 10−3 day−1 [29]
σ Recovery rate for humans 0.1428 day−1 [4, 29]
ηh,ηv Modifications parameter [0, 1) [29]
µv Natural mortality rate of vectors
[
1
30
, 1
14
]
day−1 [4, 29]
γv Progression rate from Ev to Iv
[
1
21
, 1
2
]
day−1 [23, 55]
βvh Probability of transmission of 0.1, 0.75 day
−1 [4, 29]
infection from an infected human
to a susceptible vector
θ Maturation rate from pupae to adult 0.08 day−1 [23, 43, 44]
µb Number of eggs at each deposit 6 day
−1 [23, 43, 44]
ΓE Carrying capacity for eggs 10
3, 106 [4, 43]
ΓL Carrying capacity for larvae 5× 102, 5× 105 [4, 43]
µE Eggs death rate 0.2 or 0.4 [44]
µL Larvae death rate 0.2 or 0.4 [44]
µP Pupae death rate 0.4 Assumed
s Transfer rate from eggs to larvae 0.7 day−1 [44]
l Transfer rate from larvae to pupae 0.5 day−1 [43]
Remark 1. (i) It is important to note that, in the case of other arboviral diseases (e.g, Chikun-
gunya), the exposed humans and vectors do not play any role in the infectious process, in this
case ηh = ηv = 0.
(ii) The model (6) is the same that we studied in a previous work (see model 18 in [2]) to
show that the backward bifurcation is caused by the disease–induced death in human. In this
previous work, we have just showed that the occurrence of the backward bifurcation is possible in
the model without vaccination. In the present work, we give a sufficient and necessary condition
, as well as the explicit expressions of the thresholds which governing this phenomenon.
2.1 Basic properties and equilibria
The rates of change of the total populations of humans (2) and adult vectors (5) for the basic
arboviral model (6) are,
N˙h = Λh − µhNh − δIh,
N˙v = θP − µvNv.
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Therefore, by standard arguments (see [1, 2, 43]) it follows that the feasible region for model
(6) is
D =
{
(Sh, Eh, Ih, Rh, Sv, Ev, Iv, E, L, P ) ∈ R10+ : Nh ≤ Λh/µh;E ≤ KE ;L ≤ KL;P ≤
lKL
k7
;Nv ≤ θlKL
k7k8
}
,
where R10+ represents the non-negative orthant of R
10.
The model is epidemiologically (the state variables have a valid physical interpretation) and
mathematically (the system of equations has a unique solution that is bounded and exists for
all time) well-posed in the region D.
For easier readability, we introduce the following quantities,
k1 := µh; k3 := µh + γh; k4 := µh + δ + σ, k5 := s + µE;
k6 := l + µL; k7 := θ + µP ; k8 := µv; k9 := µv + γv; k10 = ηhk4 + γh; k11 = ηvk8 + γv,
(7)
and (the positive quantity), k2 = k3k4 − δγh = µhk4 + γh(µh + σ).
Without disease in the both populations (i.e λh = λv = 0 or Eh = Ih = Ev = Iv = 0), the ba-
sic arboviral model (6) have two disease–free equilibria given by E0 = (N0h , 0, 0, 0, 0, 0, 0, 0, 0, 0)
which correspond to the trivial equilibrium, and E1 = (N0h , 0, 0, 0, N0v , 0, 0, E, L, P ) which cor-
respond to the biological disease–free equilibrium, where
N0h =
Λh
µh
, N0v =
ΓEΓLk5k6 (N − 1)
µb (ΓEs+ k6ΓL)
, P =
ΓEΓLk5k6k8 (N − 1)
µbθ (ΓEs + k6ΓL)
L =
ΓEΓLk5k6k7k8 (N − 1)
µbθl (ΓEs+ k6ΓL)
, E =
ΓEΓLk5k6k7k8 (N − 1)
s (µblΓLθ + k5k7k8ΓE)
,
(8)
and N is the net reproductive number [2, 43] given by
N = µbθls
k5k6k7k8
. (9)
Define the basic reproductive number [21, 59]
R0 =
√
a2βhvβvh(γh + k4ηh)(γv + k8ηv)N
0
v
k3k4k8k9N0h
. (10)
We note that,
R0 =
√
KvhKhv,
where,
Kvh = (K
Eh
vh +K
Ih
vh)
= (a) (βvh)
(
N0v
N0h
)(
1
k3
)[
(ηh) +
(
γh
k4
)]
=
aβvh(γh + k4ηh)N
0
v
k3k4N0h
,
is the number of vector that one human infects through his/her latent/infectious life time. It is
equal to the sum of the number of vector infections generated by an exposed human (near the
DFE, E1) KEhvh , and the number of vector infections generated by an infectious human (near the
DFE)KIhvh. K
Eh
vh is given by the product of the infection rate of exposed humans (aβvhηhN
0
v /N
0
h)
and the average duration in the exposed (Eh ) class (1/k3). K
Ih
vh is given by the product of
the infection rate of infectious humans (aβvhN
0
v /N
0
h), the probability that an exposed human
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survives the exposed stage and move to the infectious stage (γh/(µh + γh)) and the average
duration in the infectious stage (1/(µh + δ + σ)).
Analogously, we have
Khv = K
Ev
hv +K
Iv
hv
= (a) (βhv)
(
1
k9
)(
ηv +
γv
k8
)
=
aβhv(γv + k8ηh)
k8k9
,
which is the number of humans that one vector infects through its infectious life time. It is
equal to the sum of the number of human infections generated by an exposed vector (near the
DFE, E1),KEvhv , and the number of human infections generated by an infectious vector (near the
DFE), KIvhv. K
Ev
hv is given by the product of the infection rate of exposed vectors (aβvhηh) and
the average duration in the exposed (Ev ) class (1/(µv + γv)). K
Iv
vh is given by the product of
the infection rate of infectious humans (aβvh), the probability that an exposed human survives
the exposed stage and move to the infectious stage (γh/k9) and the average duration in the
infectious stage (1/k8). The basic reproduction number is equal to the geometric mean of Kvh
and Khv because infection from human to human goes through one generation of vectors.
The local asymptotic stability result of equilibria E0 and E1 is given in the following.
Theorem 1.
(i) if N ≤ 1, the trivial equilibrium E0 is locally asymptotically stable in D;
(ii) if N > 1, the trivial equilibrium is unstable and the disease–free equilibrium E1 is locally
asymptotically stable in D whenever R0 < 1.
Proof. See appendix A. .
The epidemiological implication of item (ii) in Theorem 1 is that, in general, when the
basic reproduction number, R0 is less than unity, a small influx of infectious vectors into the
community would not generate large outbreaks, and the disease dies out in time (since the DFE
is locally asymptotically stable) [2, 29, 21, 59, 17]. However, we will show in the subsection 2.2
that the disease may still persist even when R0 < 1.
The global stability of the trivial equilibrium is given by the following result:
Theorem 2. If N ≤ 1, then E0 is globally asymptotically stable on D.
Proof. See appendix B.
We now show the existence of endemic equilibria, that is, steady states of model (6) where
all state variables are positive. First we introduce:
ψ = k10aµhβvh − δγhk8, (11)
Rc =
√
2k8k2 + k10aµhβvh
k3k4k8
, (12)
R1b = 1
k3k4
(√
1
k8k9
) ∣∣∣√δγh(aµhβvhk10 + k2k8)−√(−k2ψ)∣∣∣ , (13)
R2b = 1
k3k4
(√
1
k8k9
)(√
δγh(aµhβvhk10 + k2k8) +
√
(−k2ψ)
)
. (14)
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Note that (as shown in the Appendix C), when Rc < R0 < 1, ψ ≤ 0 and correspondingly,
R1b and R2b are real.
With the inequalities,
Rc < R0 < min(1,R1b), (15a)
max(Rc,R2b) < R0 < 1, (15b)
we claim the following result:
Theorem 3. The number of endemic equilibrium points of the basic arboviral disease model (6)
depends on R0 as follows:
(i) For R0 > 1, the system has a unique endemic equilibrium point.
(ii) For R0 = 1, the system has
(a) A unique endemic equilibrium point if Rc < 1.
(b) No endemic equilibrium points otherwise.
(iii) For R0 < 1, the system has
(a) Two endemic equilibrium points if either inequality (15a) or (15b) is satisfied.
(b) A unique endemic equilibrium point if Rc < R0 and either R0 = R1b or R0 = R2b.
(c) No endemic equilibrium points otherwise.
Proof. See appendix C.
It is clear that case (iii) (item (a)) of theorem 3 indicate the possibility of backward bi-
furcation (where the locally-asymptotically stable DFE co-exists with a locally asymptotically
stable endemic equilibrium when R0 < 1) in the model (6). In a previous work (see model 18
in [2]), we just showed that the model exhibited the backward bifurcation phenomenon. In the
following, we provide not only a sufficient condition, but also the thresholds which governing
this phenomenon.
2.2 Bifurcation analysis
Here, we use the centre manifold theory [31] to explore the possibility of bifurcation in (3)
at criticality (i.e. the existence and stability of the equilibrium points bifurcating from E1 at
R0 = 1) by studying the centre manifold near the criticality through the approach developed in
[59, 24, 14, 12], which is based on general centre manifold theory [31]. To do so, a bifurcation
parameter β∗hv is chosen, by solving for βhv from R0 = 1, giving
β∗hv =
k3k4k8k9N
0
h
a2βvhk10k11N0v
. (16)
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Let Jβ∗
hv
denotes the Jacobian of the system (3) evaluated at the DFE (E1 ) and with βhv = β∗hv.
Thus, J =


−k1 0 0 0 0 −β∗hvηv −β∗hv 0 0 0
0 −k3 0 0 0 β∗hvηv β∗hv 0 0 0
0 γh −k4 0 0 0 0 0 0 0
0 0 σ −µh 0 0 0 0 0 0
0 −βvhηhS
0
v
N0h
−βvhS
0
v
N0h
0 −k8 0 0 0 0 θ
0
βvhηhS
0
v
N0h
βvhS
0
v
N0h
0 0 −k9 0 0 0 0
0 0 0 0 0 γv −k8 0 0 0
0 0 0 0 K1 K1 K1 −K2 0 0
0 0 0 0 0 0 0 K3 −K4 0
0 0 0 0 0 0 0 0 l −k7


,
with K1 = µb
(
1− E
∗
KE
)
, K2 = k5 +
µb
KE
S0v . K3 = s
(
1− L
∗
KL
)
, and K4 =
(
k6 +
sE∗
KL
)
.
Note that the system (6), with βhv = β
∗
hv, has a hyperbolic equilibrium point, i.e., the
linearised system (6) has a simple eigenvalue with zero real part and all other eigenvalues
have negative real part (this follows from the loss of stability of the disease–free equilibrium, E1
through the transcritical bifurcation). Hence, the centre manifold theory [59, 24, 14, 31, 12] can
be used to analyse the dynamics of the model (3) near βhv = β
∗
hv. The technique in Castillo-
Chavez and Song (2004) [14] entails finding the left and right eigenvectors of the linearised
system above as follows.
The left eigenvector components of Jβ∗
hv
, which correspond to the uninfected states are zero
(see Lemma 3 in [59]). Thus a non-zero components correspond to the infected states. It follows
that the matrix Jβ∗
hv
has a left eigenvector given by v = (v1, v2, . . . , v10), where
v1 = v4 = v5 = v8 = v9 = v10 = 0; v2 =
k8
β∗hv
v7; v3 =
βvhS
0
v(ηvk8 + γv)
k4k9N0h
v7;
v6 =
(ηvk8 + γv)
k9
v7, v7 > 0.
(17)
Similarly, the component of the right eigenvector w are given by
w7 > 0, w10 > 0,
w1 = −β
∗
hv(ηvk8 + γv)
γvk1
w7; w4 =
β∗hvγhσ(ηvk8 + γv)
µhγvk3k4
w7; w2 =
µhk4
γhσ
w4; w3 =
µh
σ
w4;
w5 = −k8 + γv
γv
w7 +
k7K2K4
lK1K3
w10; w6 =
k8
γv
w7; w8 =
k7K4
lK3
w10; w9 =
k7
l
w10.
(18)
Theorem 4.1 in Castillo-Chavez and Song [14] is then applied to establish the existence of
backward bifurcation in (6). To apply such a theorem, it is convenient to let fk represent the
right-hand side of the kth equation of the system (3) and let xk be the state variables whose
derivative is given by the kth equation for k = 1, . . . , 10. The local bifurcation analysis near
the bifurcation point (βhv = β
∗
hv) is then determined by the signs of two associated constants,
denoted by A1 and A2, defined by
A1 =
10∑
k,i,j=1
vkwiwj
∂2fk(0, 0)
∂xi∂xj
and A2 =
10∑
k,i=1
vkwi
∂2fk(0, 0)
∂xi∂φ
(19)
with φ = βhv − β∗hv. It is important to note that in fk(0, 0), the first zero corresponds to the
disease–free equilibrium, E1, for the system (6). Since βhv = β∗hv is the bifurcation parameter,
it follows from φ = βhv − β∗hv that φ = 0 when βhv = β∗hv which is the second component in
fk(0, 0).
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Using Eqs. (17) and (18) in Eq. (19), we obtain
A1 = v2
10∑
i,j=1
wiwj
∂2f2(0, 0)
∂xi∂xj
+ v6
10∑
i,j=1
wiwj
∂2f6(0, 0)
∂xi∂xj
and A2 = v2
10∑
i=1
wi
∂2f2(0, 0)
∂xi∂φ
(20)
It follows then, after some algebraic computations (see the details in appendix D), that
A1 = ζ1 − ζ2, (21)
where we have set (see the appendix D for details on derivation of this quantity)
ζ1 =
{
2
k7K2K4
lK1K3
aβvh
N0h
(ηhw2 + w3)w10 − 2aβvhS
0
v
(N0h)
2
(ηhw2 + w3)w1
}
v6
ζ2 = 2
aβ∗hv
N0h
(ηvw6 + w7) (w2 + w3 + w4)v2
+ 2
aβvh
N0h
{
S0v
N0h
(
ηhw
2
2 + (ηh + 1)w2w3 + ηhw2w4 + ηhw
2
3 + w3w4
)
+
(k8 + γv)
γv
(ηhw2 + w3)w7
}
v6
(22)
According to (17) and (18), we have ζ1 > 0 and ζ2 > 0.
We then have
A2 = aS
0
v
N0h
(ηhw6 + w7) v2.
Note that the coefficient A2 is always positive. Thus, using Theorem 4.1 in [14], the following
result is established.
Theorem 4. The basic model (6) exhibits a backward bifurcation at R0 = 1 whenever A1 > 0
(i.e., ζ1 > ζ2). If the reversed inequality holds, then the bifurcation at R0 = 1 is forward.
The direct consequence of Theorem 4 is the following.
Corollary 1. If A1 < 0 (i.e., ζ1 < ζ2), then the unique endemic equilibrium point of the basic
model (6) is locally asymptotically stable whenever R0 > 1.
The backward bifurcation phenomenon is illustrated by numerical simulation of the model
with the following set of parameter values (it should be noted that these parameters are chosen
for illustrative purpose only, and may not necessarily be realistic epidemiologically): Λh = 30,
βhv = 0.008, ηh = 0.78, ηv = 0.99, δ = 1, σ = 0.01428, βvh = 0.5, γv = 1/14, ΓE = 10
4,
ΓL = ΓE/2. All other parameters are as in Table 2. In this case the conditions required by
Theorem 3, case (iii), are satisfied, as well as ζ1 = 1.0772 × 10−7 > ζ2 = 1.0250 × 10−9 (so
A1 = 1.0669× 10−7 > 0) in Theorem 4. Note, in particular, that with this set of parameters,
Rc = 0.0367 < 1, R0 = 0.4359 < 1 (so thatRc < R0 < 1). It follows: d2 = −5.6537×10−8 < 0,
d1 = 1.1504×10−10 > 0 and d0 = −2.4857×10−14 < 0, so that d21−4d2d0 = 7.6134×10−21 > 0.
The resulting two endemic equilibria E2 = (S∗h, E∗h, I∗h, R∗h, S∗v , E∗v , I∗v , E, L, P ), are:
E∗2 = (16394, 16384, 29, 10092, 6558, 406, 869, 8393, 31334, 3264),
which is locally stable and
E∗∗2 = (104660, 104660, 25, 8850, 7530, 97, 206, 8393, 31334, 3264),
which is unstable.
The associated bifurcation diagram is depicted in figure 2. This clearly shows the co-
existence of two locally-asymptotically stable equilibria when R0 < 1, confirming that the
model (6) undergoes the phenomenon of backward bifurcation.
The occurrence of the backward bifurcation can be also seen in Figure 3. Here, R0 is less
than the transcritical bifurcation threshold R0 = 1 (R0 = 0.4359 < 1), but the solution of the
12
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Figure 2: The backward bifurcation curves for model system (6) in the (R0, I∗h) and (R0, I∗v )
planes. The parameter βhv varied in the range [0, 0.0877] to allow R0 to vary in the range
[0, 1.5]. Two endemic equilibrium points coexist for values of R0 in the range (0.2671, 1)
(corresponding to the range (0.0028, 0.0390) of βhv). The notation EE and DFE stand for
endemic equilibrium and disease–free equilibrium, respectively. Solid lines represent stable
equilibria and dash lines stand for unstable equilibria.
model (6) can approach either the endemic equilibrium point or the disease-free equilibrium
point, depending on the initial condition.
We know from Theorem 4 that a backward bifurcation scenario is possible for model (6).
Here, we characterize the critical value in terms of a single parameter, the transmission rate
βhv, at which the saddle–node bifurcation occurs, i.e. the threshold for the appearance of two
endemic equilibria (see Figure 2).
We follow the approach given in [52]. Introducing the quantities,
β =
[aµhβvhk10 + 2k2k8]N
0
h
a2βvhk10k11N0v
, (23)
and,
β± =
N0h
k3k4k10k11a2N0vβvh
{√
δγh(aµhβvhk10 + k2k8)±
√
(−k2ψ)
}2
, (24)
we have the following result (see the Appendix E for the proof).
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Figure 3: Solutions of model (6) of the number of infectious humans, Ih, and the number of
infectious vectors, Iv, for parameter values given in the bifurcation diagram in Figure 2 with
βhv = 0.008, so R0 = 0.4359 < 1, for two different set of initial conditions. The first set of
initial conditions (corresponding to the dotted trajectory) is Sh = 700, Eh = 220, Ih = 15,
Rh = 60, Sv = 3000, Ev = 400, Iv = 120, E = 10000, L = 5000 and P = 3000. The second set
of initial conditions (corresponding to the solid trajectory) is Sh = 733650, Eh = 220, Ih = 15,
Rh = 60, Sv = 3000, Ev = 400, Iv = 120, E = 10000, L = 5000 and P = 3000. The solution for
initial condition 1 approaches the locally asymptotically stable DFE point, while the solution
for initial condition 2 approaches the locally asymptotically stable endemic equilibrium .
Theorem 5. Assume that ψ < 0, where ψ is given by (11). Then the backward bifurcation
phenomenon takes place in the basic model (6) if and only if
β¯hv < βhv < min(β−, β
∗
hv) or max(β¯hv, β+) < βhv < β
∗
hv. (25)
The previous analysis is in line with the observation made by Wangari et al. in [61] con-
cerning the bifurcation thresholds of epidemiological models.
2.3 Non-existence of endemic equilibria for R0 < 1 and δ = 0
In this case, we have the following result.
Theorem 6. (i) The model (6) without disease–induced death (δ = 0) has no endemic equilib-
rium when R0,δ=0 ≤ 1, and has a unique endemic equilibrium otherwise.
14
(ii) The DFE, E1, of model (6) without disease–induced death (δ = 0), is globally asymptotically
stable (GAS) in D if R0,δ=0 < 1.
Proof. See appendix F.
2.4 Sensitivity analysis
We carried out the sensitivity analysis to determine the model robustness to parameter values.
That is to help us to know the parameters that are most influential in determining disease
dynamics. Following the approach by Marino et al. [42] and Wu et al. [66], partial rank
correlation coefficients (PRCC) between the basic reproduction number R0 and each parameter
are derived from 5,000 runs of the Latin hypercube sampling (LHS) method, which is a stratified
Monte Carlo sampling method that divides each parameter’s range into N equal intervals and
randomly draws one sample from each interval [66, 58]. The parameters are assumed to be
random variables with uniform distributions with their mean value listed in Table 2.
With these 5,000 runs of LHS, the derived distribution of R0 is given in Figure 4. This
sampling shows that the mean of R0 is 1.9583 and the standard deviation is 1.8439. This
implies that for the mean of parameter values given in Table 2, we may be confident that the
model predicts an endemic state, since the basic reproduction number is greater that unity.
The probability that R0 > 1 (the disease–free equilibrium is unstable and there is exactly one
endemic equilibrium point) is 64.48%.
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Figure 4: Sampling distribution of R0 from 5,000 runs of Latin hypercube sampling. The mean
of R0 is 1.9583 and the standard deviation is 1.8439. Furthermore, P(R0 ≥ 1) = 64.48%.
We also evaluate the probabilities that conditions (i), (ii) and (iii) in Theorem 3 are satisfied.
Let us set P[X ] the probability of X , and the sets of parameter values for which (N > 1) is true
by Φ1, the sets of parameter values for which (Rc < R0 < min(1,R1b)) or (max(Rc,R2b) <
15
R0 < 1) by Φ2, and the sets of parameter values for which {(R0 = R1b) or (R0 = R2b)} by Φ3,
P [¬Φ1] = P [N ≤ 1] = 0.0020, (26a)
P [Φ1] = P [N > 1] = 0.9980, (26b)
P [Φ1 and (R0 < 1) and Φ2 ] = 0.0026, (26c)
P [Φ1 and (R0 < 1) and Φ3] = 0, (26d)
P [Φ1 and(R0 < 1) and ¬Φ2 and ¬Φ3] = 0.3526, (26e)
P [Φ1 and (R0 < 1)] = 0.3552, (26f)
P [Φ1 and (R0 ≥ 1)] = 0.6448. (26g)
Therefore, the probability that the trivial disease–free equilibrium is locally asymptotically
stable is 0.0020 (from (26a)), the probability that the disease free equilibrium point is locally
asymptotically stable is 0.3552 (from (26f)), the probability that the disease free equilibrium
point is locally asymptotically stable and (i) there are no endemic equilibrium points is 35.26%
(ii) there are exactly one endemic equilibrium point is 0 (from (26d)), (iii) there are exactly two
endemic equilibrium points is 0.0026 (from (26c)). This implies that for the ranges of parameter
values given in Table 4, the disease-free equilibrium point is likely to be locally asymptotically
stable and the probability of co-existence of a locally asymptotically stable endemic equilibrium
point (occurrence of backward bifurcation phenomenon) is very small and insignificant.
We now use sensitivity analysis to analyse the influence of each parameter on the basic
reproductive number. From the previously sampled parameter values, we compute the PRCC
between R0 and each parameter of model (3). The parameters with large PRCC values (> 0.5
or < −0.5) statistically have the most influence [66].
Table 3: Partial Rank Correlation Coefficients between R0 and each parameters of model (6).
Parameter Correlation Parameter Correlation Parameter Correlation
Coefficients Coefficients Coefficients
βvh 0.7345 ΓL 0.3813 µh 0.1717
βhv 0.7285 ΓE 0.3698 γv 0.0872
a 0.6454 s 0.3733 ηv 0.06891
θ 0.6187 µP –0.2565 µL –0.0556
µv –0.5521 ηh 0.2331 µb 0.0531
Λh –0.5435 γh –0.2204 µE –0.0022
l 0.5144 σ –0.1867 δ 0.0003
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Figure 5: Partial rank correlation coefficients for R0
The results, displayed in Table 3 and Figure 5, show that the basic reproduction number
R0 outcome measures are sensitive to changes in the parameters βvh, βhv, a, θ, µv, Λh and l.
The sensitivity results suggest that the control of the epidemic of arboviral diseases pass
through a combination of immunization against arbovirus, individual protection against vector
bites, treatment of infected human, and vector control mechanisms.
3 A Model for Optimal Control
There are several possible interventions in order to reduce or limit the proliferation of mosquitoes
and the explosion of the number of infected humans and mosquitoes. In addition of controls
used in [44], we add vaccination and the control of adult vectors as control variables to reduce
or even eradicate the disease. So we introduce five time dependent controls:
1. The first control 0 ≤ u1(t) ≤ 1 denotes the percentage of susceptible individuals that one
decides to vaccinate at time t. A parameter ω associated to the control u1(t) represents
the waning immunity process [50].
2. The second control 0 ≤ u2(t) ≤ 1 represents efforts made to protect human from mosquito
bites. It mainly consists to the use of mosquito nets or wearing appropriate clothes [44].
Thus we modify the infection term as follows:
λch = (1− α1u2(t))λh, , λcv = (1− α1u2(t))λv (27)
where α1 measures the effectiveness of the prevention measurements against mosquito
bites.
3. The third control 0 ≤ u3(t) ≤ 1 represents efforts made for treatment. It mainly consists
in isolating infected patients in hospitals, installing an anti-mosquito electric diffuser in
the hospital room, or symptomatic treatments [44]. Thus we modify the recovery rate
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such that σch := σh+α2u3. α2 is the effectiveness of the anti-arboviral diseases drugs with
α2 = 0.3 [44]. Note that this control also permit to reduce the disease-induced death.
4. The fourth control 0 ≤ u4(t) ≤ 1 represents mosquitoes adulticiding effort with killing
efficacy cm. Thus the mosquito natural mortality rate becomes µ
c
v = µv + cmu4(t).
5. The fifth control 0 ≤ u5(t) ≤ 1 represents the effect of interventions used for the vector
control. It mainly consists in the reduction of breeding sites with chemical application
methods, for instance using larvicides like BTI (Bacillus Thuringensis Israelensis) which
is a biological larvicide, or by introducing larvivore fish. This control focuses on the
reduction of the number of larvae, and thus eggs, of any natural or artificial water-filled
container [44]. Thus the eggs and Larvae natural mortality rate become µcE = µE+η1u5(t)
and µcL = µL+η2u5(t) where η1, η2, represent the chemical eggs and larvae mortality rate,
respectively [44].
Note that 0 ≤ ui ≤ 1, for i = 1, . . . , 5, means that when the control is zero there is no any
effort invested (i.e. no control) and when it is one, the maximum control effort is invested.
Therefore, our optimal control model of arboviral diseases reads as

S˙h = Λh − [(1− α1u2(t))λh + µh + u1(t)]Sh + ωu1(t)Rh
E˙h = (1− α1u2(t))λhSh − (µh + γh)Eh
I˙h = γhEh − [µh + (1− α2u3(t))δ + σ + α2u3(t)] Ih
R˙h = (σ + α2u3(t))Ih + u1Sh − (µh + ωu1)Rh
S˙v = θP − (1− α1u2(t))λvSv − (µv + cmu4(t))Sv
E˙v = (1− α1u2(t))λvSv − (µv + γv + cmu4(t))Ev
I˙v = γvEv − (µv + cmu4(t))Iv
E˙ = µb
(
1− E
ΓE
)
(Sv + Ev + Iv)− (s+ µE + η1u5(t))E
L˙ = sE
(
1− L
ΓL
)
− (l + µL + η2u5(t))L
P˙ = lL− (θ + µP )P
(28)
with initial conditions given at t = 0.
For the non-autonomous system (28), the rate of change of the total populations of humans
and adults vectors is given, respectively, by{
N˙h = Λh − µhNh − (1− α2u3(t))δIh
N˙v = θP − (µv + cmu4(t))Nv (29)
For bounded Lebesgue measurable controls and non-negative initial conditions, non-negative
bounded solutions to the state system exist [40].
The objective of control is to minimize: the number of symptomatic humans infected with
arboviruses (that is, to reduce sub-population Ih ), the number of vector (Nv ) and the number
of eggs and larvae (that is, to reduce sub-population E and L, respectively), while keeping the
costs of the control as low as possible.
To achieve this objective we must incorporate the relative costs associated with each policy
(control) or combination of policies directed towards controlling the spread of arboviral diseases.
We define the objective function as
J(u1, u2, u3, u4, u5) =
∫ tf
0
[
D1Ih(t) +D2Nv(t) +D3E(t) +D4L(t) +
5∑
i=1
Biu
2
i (t)
]
dt (30)
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and the control set
∆ = {(u1, u2, u3, u4, u5)|ui(t) is Lebesgue measurable on [0, tf ], 0 ≤ ui(t) ≤ 1, i = 1, . . . , 5}.
The first fourth terms in the integrand J represent benefit of Ih, Nv, E and L populations,
describing the comparative importance of the terms in the functional. A high value of D1
for example, means that it is more important to reduce the burden of disease as reduce the
costs related to all control strategies [9]. Positive constants Bi, i = 1, . . . , 5 are weight for
vaccination, individual protection (human), treatment and vector control effort respectively,
which regularize the optimal control. In line with the authors of some studies on the optimal
control (see [44, 50, 62, 3, 9, 69, 34, 68]), we choose a linear function for the cost on infection,
D1Ih, D2Nv, D3E, D4L, and quadratic forms for the cost on the controls B1u
2
1, B2u
2
2, B3u
2
3,
B4u
2
4, and B5u
2
5. This choice can be justified by the following arguments:
(i) An epidemiological control can be likened to an expenditure of energy, by bringing to the
applications of physics in control theory;
(ii) In a certain sense, minimize ui is like minimize u
2
i , because ui > 0, i = 1, . . . , 5.
(iii) The quadratic controls give rise to controls as feedback law, which is convenient for
calculations.
We solve the problem using optimal control theory.
Theorem 7. Let X = (Sh, Eh, Ih, Rh, Sv, Ev, Iv, E, L, P ). The following set
Ω =
{
X ∈ R10 : Nh ≤ Λh
µh
;E ≤ ΓE ;L ≤ ΓL;P ≤ lΓL
k7
;Nv ≤ θlΓL
k7k8
}
is positively invariant under system (28).
Proof. On the one hand, one can easily see that it is possible to get,

S˙h ≥ − (λh + µh)Sh
E˙h ≥ −(µh + γh)Eh
I˙h ≥ −(µh + δ + σ)Ih
R˙h ≥ −µhRh
E˙ ≥ −( µb
KE
+ s+ µE + η1)E
L˙ ≥ −( s
KL
+ l + µL + η2)L
P˙ ≥ −(θ + µP + η3)P
S˙v ≥ −(λv + µv)Sv
E˙v ≥ −(µv + γv)Ev
I˙v ≥ −µvIv
(31)
for (Sh(0), Eh(0), Ih(0), Rh(0), E(0), A(0), P (0), Sv(0), Ev(0), Iv(0)) ≥ 0. Thus, solutions with
initial value in Ω remain nonnegative for all t ≥ 0. On the other hand, we have

N˙h ≤ Λh − µhNh
N˙v ≤ θP − µvNv
E˙ ≤ µb
(
1− E
KE
)
(Sv + Ev + Iv)− (s+ µE)E
L˙ ≤ sE
(
1− L
KL
)
− (l + µL)L
P˙ ≤ lL− (θ + µP )P
(32)
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The right hand side of the inequalities correspond to the transmission model without control,
and it is easy to show that solutions remain in Ω. Then using Gronwall’s inequality, we deduce
that solutions of (28) are bounded.
3.1 Existence of an optimal control
The existence of an optimal control can be obtained by using a result of Fleming and Rishel
[28].
Theorem 8. Consider the control problem with system (28).
There exists u⋆ = (u⋆1, u
⋆
2, u
⋆
3, u
⋆
4, u
⋆
5) such that
min
(u1,u2,u3,u4,u5)∈∆
J(u1, u2, u3, u4, u5) = J(u
⋆
1, u
⋆
2, u
⋆
3, u
⋆
4, u
⋆
5)
Proof. To use an existence result, Theorem III.4.1 from [28], we must check if the following
properties are satisfied:
1- the set of controls and corresponding state variables is non empty;
2- the control set ∆ is convex and closed;
3- the right hand side of the state system is bounded by a linear function in the state and
control;
4- the integrand of the objective functional is convex;
5- there exist constants c1 > 0 , c2 > 0 , and β > 1 such that the integrand of the objective
functional is bounded below by c1
(
5∑
i=1
|ui|2
) β
2
− c2.
In order to verify these properties, we use a result from Lukes [40] to give the existence of
solutions for the state system (28) with bounded coefficients, which gives condition 1. Since by
definition, the control set ∆ is bounded , then condition 2 is satisfied. The right hand side of
the state system (28) satisfies condition 3 since the state solutions are bounded. The integrand
of our objective functional is clearly convex on ∆, which gives condition 4. There are c1 > 0,
c2 > 0 and β > 1 satisfying D1Ih + D2Nv + D3E + D4L +
5∑
i=1
Biu
2
i ≥ c1
(
5∑
i=1
|ui|2
)β
2
− c2,
because the states variables are bounded. Thus condition 5 is satisfied. We conclude that
there exists an optimal control u∗ = (u⋆1, u
⋆
2, u
⋆
3, u
⋆
4, u
⋆
5) that minimizes the objective functional
J (u1, u2, u3, u4, u5).
3.2 Characterization of an optimal control
The necessary conditions that an optimal control must satisfy come from the Pontryagin’s
Maximum Principle (PMP) [49]. This principle converts (28)-(30) into a problem of minimizing
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point wise a Hamiltonian H, with respect to (u1, u2, u3, u4, u5):
H = D1Ih +D2Nv +D3E +D4L+
5∑
i=1
Biu
2
i
+ λSh {Λh − [(1− α1u2)λh + µh + u1]Sh + ωu1Rh}
+ λEh {[1− α1u2]λhSh − (µh + γh)Eh}
+ λIh {γhEh − (µh + (1− α2u3)δ + σ + α2u3)Ih}
+ λRh {(σ + α2u3)Ih + u1Sh − (µh + ωu1)Rh}
+ λSv {θP − [1− α1u2]λvSv − (µv + cmu4)Sv}
+ λEv {(1− α1u2)λvSv − (µv + γv + cmu4)Ev}+ λIv {γvEv − (µv + cmu4)Iv}
+ λE
{
µb
(
1− E
ΓE
)
(Sv + Ev + Iv)− (s+ µE + η1u5)E
}
+ λL
{
sE
(
1− L
ΓL
)
− (l + µL + η2u5)L
}
+ λP {lL− (θ + µP )P}
(33)
where the λi, i = Sh, Eh, Ih, Rh, Sv, Ev, Iv, E, L, P are the adjoint variables or co-state variables.
Applying Pontryagin’s Maximum Principle [49], we obtain the following result.
Theorem 9. Given an optimal control u⋆ = (u⋆1, u
⋆
2, u
⋆
3, u
⋆
4, u
⋆
5) and solutions
(S⋆h, E
⋆
h, I
⋆
h, R
⋆
h, S
⋆
v , E
⋆
v , I
⋆
v , E
⋆, A⋆, P ⋆) of the corresponding state system (28), there exist adjoint
variables Π = (λSh, λEh, λIh, λRh, λSv , λEv , λIv , λE, λL, λP ) satisfying,
dλSh
dt
= µhλSh + u1(λSh − λRh) + (1− α1u2)λh
(
1− Sh
Nh
)
(λSh − λEh) + (1− α1u2)
Svλv
Nh
(λEv − λSv ) (34)
dλEh
dt
= µhλEh + γh(λEh − λIh) + (1− α1u2)
Shλh
Nh
(λEh − λSh) + (1− α1u2)
Sv
Nh
(aβvhηh − λv) (λSv − λEv )
(35)
dλIh
dt
= −D1 + [µh + (1 − α2u3)δ]λIh + (σ + α2u3)(λIh − λRh) + (1− α1u2)
Shλh
Nh
(λEh − λSh)
+ (1− α1u2) Sv
Nh
(aβvh − λv) (λSv − λEv )
(36)
dλRh
dt
= µhλRh + ωu1(λRh − λSh) + (1− α1u2)
Shλh
Nh
(λEh − λSh) + (1− α1u2)
Svλv
Nh
(λEv − λSv ) (37)
dλSv
dt
= −D2 + (µv + cmu4)λSv + (1 − α1u2)λv(λSv − λEv )− µb
(
1− E
ΓE
)
λE (38)
dλEv
dt
= −D2 + (µv + cmu4)λEv + γv(λEv − λIv ) + aηvβhv(1− α1u2)(λSh − λEh)
Sh
Nh
− µb
(
1− E
ΓE
)
λE (39)
dλIv
dt
= −D2 + (µv + cmu4)λIv + aβhv(1− α1u2)
Sh
Nh
(λSh − λEh)− µb
(
1− E
ΓE
)
λE (40)
dλE
dt
= −D3 +
[
µb
ΓE
Nv + s+ µE + η1u5
]
λE − s
(
1− L
ΓL
)
λL (41)
dλL
dt
= −D4 − lλP +
[
s
ΓL
E + µL + l + η2u5
]
λL (42)
dλP
dt
= (µP + θ)λP − θλSv (43)
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and the transversality conditions
λ∗i (tf) = 0, i = 1, . . . 10. (44)
Furthermore,
u⋆1 = min
{
1,max
(
0,
(Sh − ωRh)(λSh − λRh)
2B1
)}
,
u⋆2 = min
{
1,max
(
0,
α1 [λhSh(λEh − λSh) + λvSv(λEv − λSv)]
2B2
)}
,
u⋆3 = min
{
1,max
(
0,
α2 [(1− δ)λIh − λRh ] Ih
2B3
)}
,
u⋆4 = min
{
1,max
(
0,
cm [SvλSv + EvλEv + IvλIv ]
2B4
)}
,
u⋆5 = min
{
1,max
(
0,
η1EλE + η2LλL
2B5
)}
.
(45)
Proof. The differential equations governing the adjoint variables are obtained by differentiation
of the Hamiltonian function, evaluated at the optimal control. Then the adjoint system can be
written as
dλSh
dt
= − ∂H
∂Sh
,
dλEh
dt
= − ∂H
∂Eh
,
dλIh
dt
= −∂H
∂Ih
,
dλRh
dt
= − ∂H
∂Rh
,
dλSv
dt
= − ∂H
∂Sv
,
dλEv
dt
= − ∂H
∂Ev
,
dλIv
dt
= −∂H
∂Iv
,
dλE
dt
= −∂H
∂E
,
dλL
dt
= −∂H
∂L
,
dλP
dt
= −∂H
∂P
,
with zero final time conditions (transversality).
To get the characterization of the optimal control given by (45), we follow [50, 39] and solve
the equations on the interior of the control set,
∂H
∂ui
= 0, i = 1, . . . , 5.
Using the bounds on the controls, we obtain the desired characterization. This ends the proof.
4 Numerical simulations and discussion
The simulations were carried out using the values of Table 4. We use an iterative scheme
to solve the optimality system. We first solve the state equations (28) with a guess for the
controls over the simulated time using fourth order Runge–Kutta scheme. Then, we use the
current iterations solutions of the state equation to solve the adjoint equations (34)– (43) by
a backward fourth order Runge–Kutta scheme. Finally, we update the controls by using a
convex combination of the previous controls and the value from the characterizations (45) (see
e.g. [44, 9, 69, 39, 45]). The values chosen for the weights in the objective functional J (see
Eq. (30)) are given in Table 5. Table 6 gives the initials conditions of state variables. We
simulated the system (28) in a period of twenty days (tf = 20).
As the purpose of our study is to seek the best combination linking vaccination to other
control mechanism, we will just determine the best strategy among the strategies listed in Table
7. Therefore, we will distinguished five control strategies at follows:
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Table 4: Value of parameters using in numerical simulations.
Parameter value Parameter value Parameter value Parameter value
µv
1
30
l 0.5 α2 0.5 γh
1
14
a 1 µE 0.2 µh
1
67∗365
γv
1
21
Λh 2.5 µb 6 θ 0.08 µP 0.4
βhv 0.75 σ 0.1428 ηv 0.35
βvh 0.75 ω 0.05 µL 0.4 δ 10
−3
ΓE 10000 s 0.7 η1 0.001 η2 0.3
ΓL 5000 ηh 0.35 cm 0.2 α1 0.5
Table 5: Numerical values for the cost functional parameters.
Parameters Value Source Parameters Value Source
D1: 10,000 [44] B1 10 Assumed
D2: 10,000 [44] B2: 10 [44]
D3: 5000 Assumed B3: 10 [44]
D4: 1 [44] B4: 10 Assumed
B5 10 [44]
Table 6: Initial conditions.
Human states Initial value Adult Vector Initial value Aquatic states Initial value
states
Sh0 : 700 Sv0 3000 E0 10000
Eh0 : 220 Ev0 400 L0 5000
Ih0 : 100 Iv0 120 P0 3000
Rh0 : 60
Table 7: Description of the different Control strategies.
Strategy Description
Z1 Vaccine combined with individual protection, treatment and adulticide
Z2 Vaccine combined with individual protection, treatment and larvicide
Z3 Vaccine combined with treatment, adulticide and larvicide
Z4 Vaccine combined with individual protection, adulticide and larvicide
Z Combination of the five controls
(i) Vaccination combined with individual protection, treatment and adulticide
With this strategy, only the combination of the control u1 on vaccination, the control u2 on
individual protection, the control u3 on treatment and the control u4 on adulticide, is used to
minimise the objective function J (30), while the other control u5 is set to zero. On figure 7,
we observed that the control strategy resulted in a decrease in the number of infected humans
(Ih) while an increase is observed in the number of infected humans (Ih) in strategy without
control. The use of this combination have also a great impact on the decreasing total vector
population (Nv), as well as aquatic vector populations (E and L).
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Figure 6: Control functions.
(ii) Vaccination combined with individual protection, treatment and larvicide
With this strategy, only the combination of the control u1 on vaccination, the control u2 on
individual protection, the control u3 on treatment and the control u5 on larvicide, is used to
minimise the objective function J (30), while the other control u4 is set to zero. On figure 8,
we observed that the control strategy resulted in a decrease in the number of infected humans
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Figure 7: Simulation results of optimal control model (28) showing the effect of using optimal
vaccination combined with individual protection, treatment and adulticide (u1 6= 0, u2 6= 0,
u3 6= 0, u4 6= 0 ).
(Ih) while an increase is observed in the number of infected humans (Ih) in strategy without
control. The use of this combination have no impact on the decreasing total vector population
(Nv), as well as aquatic vector populations (E and L).
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Figure 8: Simulation results of optimal control model (28) showing the effect of using optimal
vaccination combined with individual protection, treatment and larvicide (u1 6= 0, u2 6= 0,
u3 6= 0, u5 6= 0 ).
(iii) Vaccination combined with treatment, adulticide and larvicide
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With this strategy, only the combination of the control u1 on vaccination, the control u3 on
treatment, the control u4 on adulticide and the control u5 on larvicide, is used to minimise the
objective function J (30), while the other control u2 is set to zero. On figure 9, we observed
that the control strategy resulted in a decrease in the number of infected humans (Ih) while an
increase is observed in the number of infected humans (Ih) in strategy without control. The
use of this combination have a considerable impact on the decreasing total vector population
(Nv), as well as aquatic vector populations (E and L).
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Figure 9: Simulation results of optimal control model (28) showing the effect of using optimal
vaccination combined with treatment, adulticide and larvicide (u1 6= 0, u3 6= 0, u4 6= 0, u5 6= 0
).
(iv) Vaccination combined with individual protection, adulticide and larvicide
With this strategy, only the combination of the control u1 on vaccination, the control u2
on individual protection, the control u4 on adulticide and the control u5 on larvicide, is used
to minimise the objective function J (30), while the other control u4 are set to zero. On
figure 10, we observed that the control strategy resulted in a decrease in the number of infected
humans (Ih) while an increase is observed in the number of infected humans (Ih) in strategy
without control. The use of this combination have a great impact on the decreasing total vector
population (Nv), as well as aquatic vector populations (E and L).
(v) The combination of all the five controls
In this strategy, the combination of all the five controls is applied. On figure 11, we observed
that combining all the five controls give a better result in a decrease in the number of infected
humans (Ih), as well as, the total number of vector population (Nv), and the aquatic vector
populations (E and L).
Figures 7, 9, 10, and 11 have the same shape, which it is difficult to say what is the best
control strategy. In the following, we make an efficiency analysis and a cost effectiveness analysis
to determine the best strategy in terms of efficiency and cost
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Figure 10: Simulation results of optimal control model (28) showing the effect of using optimal
vaccination combined with individual protection, adulticide and larvicide (u1 6= 0, u2 6= 0,
u4 6= 0, u5 6= 0 ).
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Figure 11: Simulation results of optimal control model (28) showing the effect of using the
combination of all the five controls (ui 6= 0, i = 1, . . . , 5).
4.1 Efficiency analysis
In line with Yang and Ferreira [67], Dumont and Chiroleu [23], and Carvalho et al. [13], we
compare the effects of different strategies applied on the arboviral diseases, by the introduction
of the efficiency index, designed by F. To this aim, we define the variable A as the area
comprised between the curve of the symptomatic infectious human (Ih) population size, for
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instance, and the time axis during the period of time from 0 to tf , as
A =
∫ th
0
Ih(t)dt, (46)
which measures the cumulated number of infectious human during the time interval [0, tf ]
[13, 67]. Hence the efficiency index, F, be can defined by
F =
(
1− A
c
h
A(0)h
)
× 100, (47)
where Ach and A0h are the cumulated number of infectious human with and without the different
controlling mechanisms, respectively. So, It follows that the best strategy will be the one whom
efficiency index will be the biggest [13, 67].
With the previous simulations, we resume the efficiency index of different strategies in the
Tables 8.
Table 8: Table of efficiency index (the case of infected humans).
Strategy AIh = FIh = 100× Strategy AIh = FIh = 100×∫ th
0
Ih(t)dt
(
1− A
c
Ih
A(0)Ih
) ∫ th
0
Ih(t)dt
(
1− A
c
Ih
A(0)Ih
)
No controls 4.1052× 103 0% Z1 490.6350 88.048451%
Z2 528.9018 87.116296% Z3 580.5772 85.857517%
Z4 1.8391× 103 55.200721% Z 490.6350 88.048451%
From table 8, we can conclude that the best strategies are Z1 and Z.
Remark 2. The same reasoning (about efficiency analysis) can be done for vector population,
by replacing Ih by Nv, and Ah by ANv in Eq. (46) and (47), respectively.
4.2 Cost Effectiveness Analysis
The analysis of efficiency allowed us to determine the most efficient strategy, regardless of the
cost associated with each control. In what follows, we will among the strategies listed in Table 7,
determine which one is the most efficient and which can be implemented at lower cost. To this
aim, we follow Okosun and co-workers [45], and use cost effectiveness analysis to determine
the most cost effective strategy to use the controls of arboviral diseases (Strategies Z1 − Z).
To this aim, we calculate the Incremental Cost-Effectiveness Ratio (ICER) which is generally
described as the additional cost per additional health outcome (see [45]).
Based on the model simulation results, we rank the strategies in decreasing number of Total
number of infectious individuals (see Table 9).
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Table 9: Cost Effectiveness of different strategies.
Strategies Total number of infected Total infection Total cost($)
individuals averted
Z4 1839 87538 7.6218× 108
Z3 581 88796 7.6093× 108
Z2 529 88848 1.6452× 109
Z1 491 88886 7.6081× 108
Z 491 88886 7.6081× 108
The difference between the total number of infectious individuals without control and the
total number of infectious individuals with control was used to determine the ”total number of
infection averted” used in the tables of cost–effectiveness analysis.
We obtain the ICER of strategies (i) and (j) by applying the formula given by equation
(48).
ICER(i) =
Total cost(i)
Total infection averted(i)
ICER(j) =
Total cost(j)− Total cost(i)
Total infection averted(j)− Total infection averted(i)
(48)
Table 10: Strategy Z4 vs Strategy Z3.
Strategies Total infection averted Total cost ($)
Z4 87538 7.6218× 108
Z3 88796 7.6093× 108
ICER(Z4) =
7.6218× 108
87538
= 8706.8473
ICER(Z3) =
(7.6093− 7.6218)× 108
88796− 87538 = −993.6407
(49)
The comparison between ICER(Z4) and ICER(Z3) shows a cost saving of $ 993.6407 for strategy
Z3 over strategy Z4. The negative ICER for strategy Z3 indicates that the strategy Z4 is
”strongly dominated”. That is, strategy Z4 is more costly and less effective than strategy Z3.
Therefore, strategy Z4, the strongly dominated is excluded from the set of alternatives so it
does not consume limited resources.
We exclude strategy Z4 and compare strategy Z3 with Z2. From table 9, we have:
Table 11: Strategy Z3 vs Strategy Z2.
Strategies Total infection averted Total cost ($)
Z3 88796 7.6093× 108
Z2 88848 1.6452× 109
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This leads to the following values for the ICER,
ICER(Z3) =
7.6093× 108
88796
= 8569.4175
ICER(Z2) =
1.6452× 109 − 7.6093× 108
88848− 88796 = 17005192
(50)
The comparison between ICER(Z3) and ICER(Z2) shows a cost saving of $ 8569.4175 for
strategy Z3 over strategy Z2. That is, strategy Z2 is more costly and less effective than strategy
Z3. Therefore, strategy Z2, the strongly dominated is excluded.
We then compare strategy Z3 with Z1. From table 9, we have:
Table 12: Strategy Z3 vs Strategy Z1.
Strategies Total infection averted Total cost ($)
Z3 88796 7.6093× 108
Z1 88886 7.6081× 108
This leads to the following values for the ICER,
ICER(Z3) =
7.6093× 108
88796
= 8569.4175
ICER(Z1) =
7.6081× 108 − 7.6093× 108
88886− 88796 = −1333.3333
(51)
The comparison between ICER(Z3) and ICER(Z1) shows a cost saving of $ 1333.3333 for
strategy Z1 over strategy Z3. So the strategy Z3 is ”strongly dominated”. That is, strategy
Z3 is more costly and less effective than strategy Z1. Therefore, strategy Z3, the strongly
dominated is excluded.
We then compare strategy Z1 with Z. From table 9, we have
Table 13: Strategy Z1 vs Strategy Z.
Strategies Total infection averted Total cost ($)
Z1 88886 7.6081× 108
Z 88886 7.6081× 108
From Table 13, it follows that strategy Z3 is equivalent in term of efficiency and cost at
strategy Z.
With these results, we conclude that the strategies Z (combination of the five control) and
Z3 (vaccination u1 combined with personal protection u2, the treatment of individuals with
clinical signs of the disease u3, killing adult vectors with adulticide, u4) are most cost-effective
that all the strategies studied in this work.
5 Conclusion
In this paper, we derived and analysed a model for the control of arboviral diseases with non
linear form of infection and complete stage structured model for vectors, and which takes
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into account a vaccination with waning immunity, treatment, individual protection and vector
control strategies (adult vectors, eggs and larvae reduction strategies).
We have begun by calculate the net reproductive number N and the basic reproduction
number R0, of the basic model (the model without control), and investigate the existence and
stability of equilibria. The stability analysis revealed that for N ≤ 1, the trivial equilibrium
is globally asymptotically stable. When N > 1 and R0 < 1, the disease–free equilibrium is
locally asymptotically stable. We have found that the model exhibits backward bifurcation.
The epidemiological implication of this phenomenon is that for effective eradication and control
of diseases, R0 should be less than a critical values less than one. We have explicitly derived
threshold conditions for saddle–node bifurcation in term of the transmission rate, βhv, as well
as the basic reproduction number. Then, we have proved, that the disease–induced death is
the principal cause of the backward bifurcation phenomenon in model.
Using data from literature related to the transmission dynamics of dengue fever, we also
estimated the probability that the model predicts the existence of multiple endemic equilib-
rium and of the likely stability of the disease–free equilibrium point, through Latin Hypercube
Sampling (LHS). The result showed that the model is in an endemic state, since the mean of
R0 is greater than unity. Then, using global sensitivity analysis, we have computed the Partial
Rank Correlation Coefficients between R0 and each parameter of the model. This analysis
showed that the basic reproduction number is sensitive to changes in the parameters βvh, the
probability of transmission of infection from an infected human to a susceptible vector, βhv,
the probability of transmission of infection from an infected vector to a susceptible human,
a, the average number of bites, θ, the maturation rate from pupae to adult, µv, the natural
mortality rate of vector, Λh, the recruitment rate of humans and l, the transfer rate from larvae
to pupae, which suggested that the control of the epidemic of arboviral diseases pass through a
combination of immunization against arbovirus (vaccination of susceptible humans), individual
protection against vector bites, treatment of infected human, vector control through chemical
interventions (adulticide and larvicide).
We then considered five time dependent controls as a way out, to ensure the eradication
of the disease in a finite time. We performed optimal control analysis of the model. In this
light, we addressed the optimal control by deriving and analysing the conditions for optimal
eradication of the disease and in a situation where eradication is impossible or of less benefit
compared with the cost of intervention, we also derived and analysed the necessary conditions
for optimal control of the disease.
From the numerical results and efficiency analysis, as well as, cost–effectiveness analysis, we
concluded that the optimal strategy to effectively control arboviral diseases is the combination
of vaccination, individual protection, treatment, and other mechanisms of vector control (by
chemical intervention–the adulticides). However this conclusion must be taken with caution
because of the uncertainties around the parameter values and to the budget/resource limitation.
It is also important to note that in most of the work which speak of the optimal control of
infectious diseases (see e.g. [3, 9, 69, 34, 68]), and particularly the arboviral diseases [4, 7, 44,
50, 62], cost effectiveness analysis, to our knowledge, is not did by the authors. This therefore
represents a contribution to the study of optimal control models of arboviral diseases.
In addition, the utilization of a vaccine of small efficacy could have a negative impact on
the health of the population. Indeed, for the particular case of dengue, the fact that sequential
infections with different strains can cause severe forms of the disease must be taken into account.
For instance, it is not currently known if a vaccinated individual, for which the efficacy for a
given strain is small, can develop a severe form of the disease when coming into contact with
such a strain. Also, its efficiency is higher in children 9-16 years (two thirds are immune) and in
individuals who have already been infected. The vaccine appears to contrast against-productive
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in younger children without the researchers knowing why. The results of clinical trials - which
involved more than 40,000 volunteers– were therefore not lifted all the uncertainties about the
impact of the vaccine [38]. Therefore, pending the completion of Phase III trials on the efficacy
of the vaccine against dengue (Dengvaxiar), and therefore its acceptance by public health
organizations such as WHO and the Centre for Disease Control (CDC), it is important to focus
on other control mechanisms.
All simulated intervention combinations can be considered cost-effective in the context of
available resources for health in countries affected by arboviruses. These results have the
potential to help managers control programs against arbovirus infections in high endemicity
countries by modifying the implementation of current interventions, or by adding new control
mechanisms.
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A Proof of Theorem 1
The Jacobian matrix of f =
(
S˙h, E˙h, I˙h, R˙h, S˙v, E˙v, I˙v, E˙, L˙, P˙
)T
at the Trivial equilibrium is
given by
Df(E0) =


−µh 0 0 0 0 −aβhvηv −aβhv 0 0 0
0 −k3 0 0 0 aβhvηv aβhv 0 0 0
0 γh −k4 0 0 0 0 0 0 0
0 0 σ −µh 0 0 0 0 0 0
0 0 0 0 −µv 0 0 0 0 θ
0 0 0 0 0 −k9 0 0 0 0
0 0 0 0 0 γv −µv 0 0 0
0 0 0 0 µb µb µb −k5 0 0
0 0 0 0 0 0 0 s −k6 0
0 0 0 0 0 0 0 0 l −k7


. (52)
The characteristic polynomial of Df(E0) is given by:
P (λ) = (λ− µh)2(λ− k3)(λ− k4)(λ− k9)(λ− µv)φ1(λ)
where
φ1(λ) = λ
4 + A1λ
3 + A2λ
2 + A3λ+ A4, with
A1 = µv + k7 + k6 + k5, A2 = (k7 + k6 + k5)µv + (k6 + k5) k7 + k5k6,
A3 = ((k6 + k5) k7 + k5k6)µv + k5k6k7, A4 = k5k6k7µv (1−N ) .
The roots of P (λ) are λ1 = −µh, λ1 = −k3, λ2 = −k4, λ3 = −µv, λ4 = −k9, and the others roots
are the roots of φ1(λ). Since N < 1, it is clear that all coefficients of φ1(λ) are always positive.
Now we just have to verify that the Routh–Hurwitz criterion holds for polynomial φ2(λ). To this
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aim, setting H1 = A1, H2 =
∣∣∣∣A1 1A3 A2
∣∣∣∣, H3 =
∣∣∣∣∣∣
A1 1 0
A3 A2 A1
0 A4 A3
∣∣∣∣∣∣, H4 =
∣∣∣∣∣∣∣∣
A1 1 0 0
A3 A2 A1 1
0 A4 A3 A2
0 0 0 A4
∣∣∣∣∣∣∣∣
= A4H3.
The Routh-Hurwitz criterion of stability of the trivial equilibrium E0 is given by

H1 > 0
H2 > 0
H3 > 0
H4 > 0
⇔


H1 > 0
H2 > 0
H3 > 0
A4 > 0
(53)
We have H1 = A1 > 0,
H2 = A1A2 − A3
= (k7 + k6 + k5) µ
2
v +
(
k27 + (2 k6 + 2 k5) k7 + k
2
6 + 2 k5 k6 + k
2
5
)
µv + (k6 + k5) k
2
7
+
(
k6 + k
2
5
)2
k7 + k5 k
2
6 + k
2
5 k6,
H3 = A1A2A3 −A
2
1A4 − A
2
3
=
(
(k6 + k5) k
2
7 +
(
k26 + 2k5k6 + k
2
5
)
k7 + k5k
2
6 + k
2
5k6
)
µ3v +
(
µblsθ + (k6 + k5) k
3
7 +
(
2k26 + 4k5k6 + 2k
2
5
)
k27
+
(
k36 + 4k5k
2
6 + 4k
2
5k6 + k
3
5
)
k7 + k5k
3
6 + 2k
2
5k
2
6 + k
3
5k6
)
µ2v +
(
(2k7 + 2k6 + 2k5)µblsθ +
(
k26 + 2k5k6 + k
2
5
)
k37
+
(
k36 + 4k5k
2
6 + 4k
2
5k6 + k
3
5
)
k27 +
(
2k5k
3
6 + 4k
2
5k
2
6 + 2k
3
5k6
)
k7 + k
2
5k
3
6 + k
3
5k
2
6
)
µv
+
(
k27 + (2k6 + 2k5) k7 + k
2
6 + 2k5k6 + k
2
5
)
µblsθ +
(
k5k
2
6 + k
2
5k6
)
k37 +
(
k5k
3
6 + 2k
2
5k
2
6 + k
3
5k6
)
k27 +
(
k25k
3
6 + k
3
5k
2
6
)
k7
We always have H1 > 0, H2 > 0, H3 > 0 and H4 > 0 if N < 1. Thus, the trivial equilibrium
E0 is locally asymptotically stable whenever N < 1.
We assume the net reproductive number N > 1. Following the procedure and the notation
in [59], we may obtain the basic reproduction number R0 as the dominant eigenvalue of the
next–generation matrix [21, 59]. Observe that model (6) has four infected populations, namely
Eh, Ih, Ev and Iv. It follows that the matrices F and V defined in [59], which take into account
the new infection terms and remaining transfer terms, respectively, are given by
F =


0 0 βhvηv βhv
0 0 0 0
βvhηvN
0
v
N0h
βvhN
0
v
N0h
0 0
0 0 0 0

 and V =


k3 0 0 0
−γh k4 0 0
0 0 k9 0
0 0 −γv k8

 .
The dominant eigenvalue of the next–generation matrix FV −1 is given by (10). The local
stability of the disease–free equilibrium E1 is a direct consequence of Theorem 2 in [59]. This
ends the proof.
B Proof of Theorem 2
Setting Y = X−TE withX = (Sh, Eh, Ih, Rh, Sv, Ev, Iv, E, L, P )T , A88 =
(
k5 + µb
Sv + Ev + Iv
KE
)
,
and A99 =
(
k6 + s
E
ΓL
)
. we can rewrite (3) in the following manner
dY
dt
= B(Y )Y (54)
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where
B(Y ) =


−(λh + µh) 0 0 0 0 −aβhvηvS
0
h
Nh
−aβhvS
0
h
Nh
0 0 0
λh −k3 0 0 0 aβhvηvS
0
h
Nh
aβhvS
0
h
Nh
0 0 0
0 γh −k4 0 0 0 0 0 0 0
0 0 σ −µh 0 0 0 0 0 0
0 0 0 0 −(λv + µv) 0 0 0 0 θ
0 0 0 0 λv −k9 0 0 0 0
0 0 0 0 0 γv −µv 0 0 0
0 0 0 0 µb µb µb −A88 0 0
0 0 0 0 0 0 0 s −A99 0
0 0 0 0 0 0 0 0 l −k7


.
It is clear that Y = (0, 0, 0, 0, 0, 0, 0, 0, 0, 0) is the only equilibrium. Then it suffices to consider
the following Lyapunov function L(Y ) =< g, Y > were g =
(
1, 1, 1, 1, 1, 1, 1,
k8
µb
,
k5k8
µbs
,
k5k6k8
µbsl
)
.
Straightforward computations lead that
L˙(Y ) =< g, Y˙ >def=< g,B(Y )Y >
= −µhY1 − µhY2 − (µh + δ)Y3 − µhY4 − k8
KE
(Y5 + Y6 + Y7)− k5k8
µbKL
Y8Y9 + θ
(
1− 1N
)
Y10.
We have L˙(Y ) < 0 if N ≤ 1 and L˙(Y ) = 0 if Yi = 0, i = 1, 2, . . . , 10 (i.e Sh = S0h and
Eh = Ih = Rh = Sv = Ev = Iv = E = L = P = 0). Moreover, the maximal invariant set
contained in
{
L|L˙(Y ) = 0
}
is {(0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)}. Thus, from Lyapunov theory, we
deduce that {(0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0)} and thus, E0, is GAS if and only if N ≤ 1.
C Proof of Theorem 3
Proof. In order to determine the existence of endemic equilibria, i.e., equilibria with all positive
components, say
E∗∗ = (S∗h, V ∗h , E∗h, I∗h, R∗h, S∗v , E∗v , I∗v , E, L, P ) ,
we have to look for the solution of the algebraic system of equations obtained by equating the
right sides of system (6) to zero.
Solving the equations in the model (6) in terms of λ∗h and λ
∗
v, gives
S∗h =
Λh
µh + λ∗h
, E∗h =
λ∗hS
∗
h
k3
, I∗h =
γhλ
∗
hS
∗
h
k3k4
, R∗h =
σγhλ
∗
hS
∗
h
µhk3k4
, (55)
and
S∗v =
θP
(λ∗v + k8)
, E∗v =
θPλ∗v
k9(λ∗v + k8)
, I∗v =
γvθPλ
∗
v
k8k9(λ∗v + k8)
,
E =
µbθΓEP
(k5k8ΓE + µbθP )
, L =
µbθsΓEΓLP
k6ΓL(k5k8ΓE + µbθP ) + sµbθΓEP
,
(56)
where P is solution of the following equation
f(P ) = −k7P [µbθ(sΓE + k6ΓL)P − k5k6k8ΓEΓL(N − 1)] = 0 (57)
A direct resolution of the above equation give P = 0 or P =
k5k6k8ΓEΓL(N − 1)
µbθ(sΓE + k6ΓL)
.
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Note that P = 0 corresponds to the trivial equilibrium E0. Now we consider P > 0 i.e.
N > 1. Substituting (55) and (56) into the expression of λ∗h and λ∗v and simplifying, lead the
non-zero equilibria of the basic model (6) satisfy the quadratic equation
k9µbΛh(sΓE + k6ΓL)
[
d2(λ
∗
h)
2 + d1λ
∗
h + d0
]
= 0, (58)
where di, i = 0, 1, 2, are given by
d2 = −k2 [k10aµhβvh + k2k8] < 0, (59a)
d1 = k
2
3k
2
4k8µh(R20 −R2c), (59b)
d0 = k
2
3k
2
4k8µ
2
h
(R20 − 1) . (59c)
and R0 and Rc are given by (10) and (12), respectively.
This equation may be simply analyzed through the Descartes’ rule of signs. First of all,
note that d2 is negative. Therefore the following cases are possible:
1. There is a unique endemic equilibrium if d0 > 0;
2. There is a unique endemic equilibrium if
(d1 > 0 and d0 = 0) or (d1 > 0 and d0 < 0 and d
2
1 − 4d2d0 = 0); (60)
3. There are two endemic equilibria if
d1 > 0 and d0 < 0 and d
2
1 − 4d2d0 > 0; (61)
4. There are no endemic equilibria otherwise.
We observe d0 > 0 is equivalent to R0 > 1 so statement (i) of Theorem 3 is equivalent to
point (a).
When R0 = 1, d0 = 0. We observe that d1 > 0 is equivalent to Rc < R0. Therefore,
when R0 = 1 and Rc < 1, d0 = 0 and d1 > 0, so statement (ii) a) of Theorem 3 follows from
statement (b) above. Since the condition d0 = 0 does not appear elsewhere in statements (a),
(b), or (c) above, statement (ii) b) of Theorem 3 follows from statement (d) above.
When R0 < 1, d0 < 0, and when Rc < R0, d1 > 0. We also note that for R0 < 1, when
d1 > 0, ψ ≤ 0 because ψ > 0 is equivalent to d1 < 0. Indeed,
ψ > 0⇐⇒ k10aµhβvh > δγhk8
⇐⇒ k10aµhβvhk9 + 2k8k9k2 > δγhk8k9 + 2k8k9k2
⇐⇒ a2βhvβvhk3k4k10k11µhN
0
v − k3k4µhN
0
h(k10aµhβvhk9 + 2k8k9k2) < k3k4k8k9µhN
0
h
[
(R20 − 1)k3k4 − k3k4 + δγh)
]
⇐⇒ a2βhvβvhk3k4k10k11µhN
0
v − k3k4µhN
0
h(k10aµhβvhk9 + 2k8k9k2) < k3k4k8k9µhN
0
h
[
(R20 − 1)k3k4 − k2)
]
⇐⇒ d1 < k3k4k8µh
[
(R20 − 1)k3k4 − k2)
]
< 0, sinceR0 < 1.
(62)
Consequently, we show that d21 − 4d2d0 = 0 is equivalent to,
ρ2R
4
0 + ρ1R
2
0 + ρ0 = 0, (63)
where
ρ2 = k
4
3k
4
4k
2
8µ
2
h, (64a)
ρ1 = 2k
2
3k
2
4k8µ
2
h [k2(k10aµhβvh − k8δγh)− (k10aµhβvh + k8k2)δγh] , (64b)
ρ0 = k
2
3k
2
4k
2
10a
2µ4hβ
2
vh. (64c)
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We again use Descartes’ rule of signs to analyse equation (63). The discriminant of (63) is
∆r = ρ
2
1 − 4ρ2ρ0, and can be written
∆r = −16k43k44k28k2µ4hδγh (k10aµhβvh + k8k2) (k10aµhβvh − k8δγh)
Since ρ2 > 0 and ρ0 > 0, equation (63) allows real positive solutions if and only if ρ1 < 0
and ∆r ≥ 0. Now, we express the obtained inequalities in terms of the quantities (11)–(14).
To this aim, we note that ∆r ≥ 0 is equivalent to ψ ≤ 0. From the definition of ψ (11) and
ρ1 (64b), this implies that ρ1 < 0. Therefore, equation (63) has exactly two positive solutions
given by (13) and (14). Therefore, statement (iii) b) follows from statement (b) above.
Similarly, d21−4d2d0 > 0, with d1 > 0 and d0 < 0 written in terms of the basic reproduction
number, is equivalent to
R0 < R1b or R0 > R2b, (65)
so statement (iii) a) follows from statement (c) above.
Finally, statement (iii) c) then follows from statement (d) above. Thus Theorem 3 is
established.
D Derivation of formula (21)
The local bifurcation analysis near the bifurcation point (βhv = β
∗
hv) is then determined by the
signs of two associated constants, denoted by A1 and A2, defined by
A1 =
10∑
k,i,j=1
vkwiwj
∂2fk(0, 0)
∂xi∂xj
and A2 =
10∑
k,i=1
vkwi
∂2fk(0, 0)
∂xi∂φ
(66)
with φ = βhv − β∗hv. It is important to note that in fk(0, 0), the first zero corresponds to the
disease–free equilibrium, E1, for the system (6). Since βhv = β∗hv is the bifurcation parameter,
it follows from φ = βhv − β∗hv that φ = 0 when βhv = β∗hv which is the second component in
fk(0, 0).
Using Eqs. (17) and (18) in Eq. (19), we obtain
A1 = v2
10∑
i,j=1
wiwj
∂2f2(0, 0)
∂xi∂xj
+ v6
10∑
i,j=1
wiwj
∂2f6(0, 0)
∂xi∂xj
and A2 = v2
10∑
i=1
wi
∂2f2(0, 0)
∂xi∂φ
. (67)
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Let
A(1)1 =
10∑
i,j=1
wiwj
∂2f2(0, 0)
∂xi∂xj
= w1
10∑
i,j=1
wj
∂2f2(0, 0)
∂x1∂xj
+ w2
10∑
i,j=1
wj
∂2f2(0, 0)
∂x2∂xj
+ w3
10∑
i,j=1
wj
∂2f2(0, 0)
∂x3∂xj
+ w4
10∑
i,j=1
wj
∂2f2(0, 0)
∂x4∂xj
+ w5
10∑
i,j=1
wj
∂2f2(0, 0)
∂x5∂xj
+ w6
10∑
i,j=1
wj
∂2f2(0, 0)
∂x6∂xj
+ w7
10∑
i,j=1
wj
∂2f2(0, 0)
∂x7∂xj
= w2
(
w6
∂2f2
∂Eh∂Ev
(0, 0) + w7
∂2f2
∂Eh∂Iv
(0, 0)
)
+ w3
(
w6
∂2f2
∂Ih∂Ev
(0, 0) + w7
∂2f2
∂Ih∂Iv
(0, 0)
)
+ w4
(
w6
∂2f2
∂Rh∂Ev
(0, 0) + w7
∂2f2
∂Rh∂Iv
(0, 0)
)
+ w6
(
w2
∂2f2
∂Ev∂Eh
+ w3
∂2f2
∂Ev∂Ih
+ w4
∂2f2
∂Ev∂Rh
)
+ w7
(
w2
∂2f2
∂Iv∂Eh
+ w3
∂2f2
∂Iv∂Ih
+ w4
∂2f2
∂Iv∂Rh
)
= w2
(
−aβ
∗
hvηv
N0h
w6 − aβ
∗
hv
N0h
w7
)
+ w3
(
−aβ
∗
hvηv
N0h
w6 − aβ
∗
hv
N0h
w7
)
+ w4
(
−aβ
∗
hvηv
N0h
w6 − aβ
∗
hv
N0h
w7
)
+ w6
(
−aβ
∗
hvηv
N0h
w2 − aβ
∗
hvηv
N0h
w3 − aβ
∗
hvηv
N0h
w4
)
+ w7
(
−aβ
∗
hv
N0h
w2 − aβ
∗
hv
N0h
w3 − aβ
∗
hv
N0h
w4
)
= −aβ
∗
hv
N0h
(ηvw6 + w7) (w2 + w3 + w4)− aβ
∗
hv
N0h
(w2 + w3 + w4) (ηvw6 + w7)
= −2aβ
∗
hv
N0h
(ηvw6 + w7) (w2 + w3 + w4),
and
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A
(2)
1 =
10∑
i,j=1
wiwj
∂2f6(0, 0)
∂x1∂xj
= w1
10∑
i,j=1
wj
∂2f6(0, 0)
∂x1∂xj
+ w2
10∑
i,j=1
wj
∂2f6(0, 0)
∂x2∂xj
+w3
10∑
i,j=1
wj
∂2f6(0, 0)
∂x3∂xj
+ w4
10∑
i,j=1
wj
∂2f6(0, 0)
∂x4∂xj
+w5
10∑
i,j=1
wj
∂2f6(0, 0)
∂x5∂xj
+ w6
10∑
i,j=1
wj
∂2f6(0, 0)
∂x6∂xj
+w7
10∑
i,j=1
wj
∂2f6(0, 0)
∂x7∂xj
= w1
(
w2
∂f6
∂Sh∂Eh
(0, 0) + w3
∂f6
∂Sh∂Ih
(0, 0)
)
+w2
(
w1
∂f6
∂Eh∂Sh
(0, 0) + w2
∂f6
∂E2
h
(0, 0) +w3
∂f6
∂Eh∂Ih
(0, 0) +w4
∂f6
∂Eh∂Rh
(0, 0) +w5
∂f6
∂Eh∂Sv
(0, 0)
)
+w3
(
w1
∂f6
∂Ih∂Sh
(0, 0) + w2
∂f6
∂Ih∂Eh
(0, 0) + w3
∂f6
∂I2
h
(0, 0) +w4
∂f6
∂Ih∂Rh
(0, 0) + w5
∂f6
∂Ih∂Sv
(0, 0)
)
+w4
(
w2
∂f6
∂Rh∂Eh
(0, 0) +w3
∂f6
∂Rh∂Ih
(0, 0)
)
+ w5
(
w2
∂f6
∂Sv∂Eh
(0, 0) +w3
∂f6
∂Sv∂Ih
(0, 0)
)
= w1
(
−
aβvhηhS
0
v
(N0
h
)2
w2 −
aβvhS
0
v
(N0
h
)2
w3
)
+w2
(
−
aβvhηhS
0
v
(N0
h
)2
w1 − 2
aβvhηhS
0
v
(N0
h
)2
w2 −
aβvhS
0
v
(N0
h
)2
(ηh + 1)w3 −
aβvhηhS
0
v
(N0
h
)2
w4 +
aβvhηh
N0
h
w5
)
+w3
(
−
aβvhS
0
v
(N0
h
)2
w1 −
aβvhS
0
v
(N0
h
)2
(ηh + 1)w2 − 2
aβvhηhS
0
v
(N0
h
)2
w3 −
aβvhS
0
v
(N0
h
)2
w4 +
aβvh
N0
h
w5
)
+w4
(
−
aβvhηhS
0
v
(N0
h
)2
w2 −
aβvhS
0
v
(N0
h
)2
w3
)
+w5
(
aβvhηh
N0
h
w2 +
aβvh
N0
h
w3
)
= −
aβvhηhS
0
v
(N0
h
)2
w1w2 −
aβvhS
0
v
(N0
h
)2
w1w3
−
aβvhηhS
0
v
(N0
h
)2
w1w2 − 2
aβvhηhS
0
v
(N0
h
)2
w22 −
aβvhS
0
v
(N0
h
)2
(ηh + 1)w2w3 −
aβvhηhS
0
v
(N0
h
)2
w2w4 +
aβvhηh
N0
h
w2w5
−
aβvhS
0
v
(N0
h
)2
w1w3 −
aβvhS
0
v
(N0
h
)2
(ηh + 1)w2w3 − 2
aβvhηhS
0
v
(N0
h
)2
w23 −
aβvhS
0
v
(N0
h
)2
w3w4 +
aβvh
N0
h
w3w5
−
aβvhηhS
0
v
(N0
h
)2
w2w4 −
aβvhS
0
v
(N0
h
)2
w3w4 +
aβvhηh
N0
h
w2w5 +
aβvh
N0
h
w3w5
= −2
aβvhηhS
0
v
(N0
h
)2
w1w2 − 2
aβvhS
0
v
(N0
h
)2
w1w3 − 2
aβvhηhS
0
v
(N0
h
)2
w22 − 2
aβvhS
0
v
(N0
h
)2
(ηh + 1)w2w3 − 2
aβvhηhS
0
v
(N0
h
)2
w2w4
− 2
aβvhηhS
0
v
(N0
h
)2
w23 − 2
aβvhS
0
v
(N0
h
)2
w3w4 + 2
aβvhηh
N0
h
w2w5 + 2
aβvh
N0
h
w3w5
= −2
aβvhηhS
0
v
(N0
h
)2
w22 − 2
aβvhS
0
v
(N0
h
)2
(ηh + 1)w2w3 − 2
aβvhηhS
0
v
(N0
h
)2
w2w4 − 2
aβvhηhS
0
v
(N0
h
)2
w23 − 2
aβvhS
0
v
(N0
h
)2
w3w4
+ 2
aβvh
N0
h
ηhw2w5 + 2
aβvh
N0
h
w3w5 − 2
aβvhS
0
v
(N0
h
)2
ηhw1w2 − 2
aβvhS
0
v
(N0
h
)2
w1w3
= −2
aβvhηhS
0
v
(N0
h
)2
w22 − 2
aβvhS
0
v
(N0
h
)2
(ηh + 1)w2w3 − 2
aβvhηhS
0
v
(N0
h
)2
w2w4 − 2
aβvhηhS
0
v
(N0
h
)2
w23 − 2
aβvhS
0
v
(N0
h
)2
w3w4
+ 2
aβvh
N0
h
(ηhw2 +w3)w5 − 2
aβvhS
0
v
(N0
h
)2
ηhw1w2 − 2
aβvhS
0
v
(N0
h
)2
w1w3
= −2
aβvhηhS
0
v
(N0
h
)2
w22 − 2
aβvhS
0
v
(N0
h
)2
(ηh + 1)w2w3 − 2
aβvhηhS
0
v
(N0
h
)2
w2w4 − 2
aβvhηhS
0
v
(N0
h
)2
w23 − 2
aβvhS
0
v
(N0
h
)2
w3w4
+ 2
aβvh
N0
h
(ηhw2 +w3)
(
−
k8 + γv
γv
w7 +
k7K2K4
lK1K3
w10
)
− 2
aβvhS
0
v
(N0
h
)2
ηhw1w2 − 2
aβvhS
0
v
(N0
h
)2
w1w3
= −2
aβvhS
0
v
(N0
h
)2
(
ηhw
2
2 + (ηh + 1)w2w3 + ηhw2w4 + ηhw
2
3 +w3w4
)
− 2
aβvh(k8 + γv)
γvN0h
(ηhw2 + w3)w7
+ 2
k7K2K4
lK1K3
aβvh
N0
h
(ηhw2 + w3)w10 − 2
aβvhS
0
v
(N0
h
)2
(ηhw2 +w3)w1
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It follows then, after some algebraic computations, that
A1 = v2
{
−2aβ
∗
hv
N0h
(ηvw6 + w7) (w2 + w3 + w4)
}
+ v6
{
−2aβvhS
0
v
(N0h)
2
(
ηhw
2
2 + (ηh + 1)w2w3 + ηhw2w4 + ηhw
2
3 + w3w4
)− 2aβvh(k8 + γv)
γvN0h
(ηhw2 + w3)w7
+2
k7K2K4
lK1K3
aβvh
N0h
(ηhw2 + w3)w10 − 2aβvhS
0
v
(N0h)
2
(ηhw2 + w3)w1
}
= v2
{
−2aβ
∗
hv
N0h
(ηvw6 + w7) (w2 + w3 + w4)
}
+ v6
{
−2aβvhS
0
v
(N0h)
2
(
ηhw
2
2 + (ηh + 1)w2w3 + ηhw2w4 + ηhw
2
3 + w3w4
)− 2aβvh(k8 + γv)
γvN0h
(ηhw2 + w3)w7
}
+ v6
{
2
k7K2K4
lK1K3
aβvh
N0h
(ηhw2 + w3)w10 − 2aβvhS
0
v
(N0h)
2
(ηhw2 + w3)w1
}
= v6
{
2
k7K2K4
lK1K3
aβvh
N0h
(ηhw2 + w3)w10 − 2aβvhS
0
v
(N0h)
2
(ηhw2 + w3)w1
}
+ v2
{
−2aβ
∗
hv
N0h
(ηvw6 + w7) (w2 + w3 + w4)
}
+ v6
{
−2aβvhS
0
v
(N0h)
2
(
ηhw
2
2 + (ηh + 1)w2w3 + ηhw2w4 + ηhw
2
3 + w3w4
)− 2aβvh(k8 + γv)
γvN0h
(ηhw2 + w3)w7
}
= v6
{
2
k7K2K4
lK1K3
aβvh
N0h
(ηhw2 + w3)w10 − 2aβvhS
0
v
(N0h)
2
(ηhw2 + w3)w1
}
− v2
{
2
aβ∗hv
N0h
(ηvw6 + w7) (w2 + w3 + w4)
}
− v6
{
2
aβvhS
0
v
(N0h)
2
(
ηhw
2
2 + (ηh + 1)w2w3 + ηhw2w4 + ηhw
2
3 + w3w4
)
+ 2
aβvh(k8 + γv)
γvN0h
(ηhw2 + w3)w7
}
= ζ1 − ζ2,
(68)
where we have set
ζ1 = v6
{
2
k7K2K4
lK1K3
aβvh
N0h
(ηhw2 + w3)w10 − 2aβvhS
0
v
(N0h)
2
(ηhw2 + w3)w1
}
,
ζ2 = v2
{
2
aβ∗hv
N0h
(ηvw6 + w7) (w2 + w3 + w4)
}
+ v6
{
2
aβvhS
0
v
(N0h)
2
(
ηhw
2
2 + (ηh + 1)w2w3 + ηhw2w4 + ηhw
2
3 + w3w4
)
2
aβvh(k8 + γv)
γvN0h
(ηhw2 + w3)w7
}
.
(69)
According to (17) and (18), we have ζ1 > 0 and ζ2 > 0.
We then have
A2 = v2
10∑
i=1
wi
∂2f2(0, 0)
∂xi∂φ
= v2
(
w6
∂2f2
∂Ev∂φ
(0, 0) + w7
∂2f2
∂Ev∂φ
(0, 0)
)
= v2
(
ηhw6
aS0v
N0h
+ w7
aS0v
N0h
)
=
aS0v
N0h
(ηhw6 + w7) v2.
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E Proof of Theorem 5
We follow the approach given in [52]. At this aim, note that equation (58) may be written as
F (βhv, λh) := d2(λ
∗
h)
2 + d1λ
∗
h + d0 = 0, (70)
where d2, d1 and d0 are the same coefficients as in (58). Thus, the positive endemic equilibria
of model (6) are obtained by solving (70) for positive λ∗h and substituting the results into
(55). Clearly, the coefficient d2, of (70), is always negative while d1 and d0 may change sign.
Therefore, there is a single endemic equilibrium if and only if d0 > 0, which correspond to
R0 > 1. There are two endemic equilibria if and only if d0 < 0, d1 > 0 and d21 − 4d2d0 > 0.
Now, first remember that d0 < 0 (i. e. R0 < 1) is equivalent to βhv < β∗hv, where β∗hv is given
at Eq. (16).
Then, inequality d1 > 0, is equivalent to
βhv > β¯ (71)
where β¯ is given by (23).
Finally, equation d21 − 4d2d0 = 0, in terms of βhv, is equivalent to
α2β
2
hv + α1βhv + α0 = 0, (72)
where α2 = k
2
3k
2
4k
2
10k
2
11a
4µ2h(N
0
v )
2β2vh, α0 = k
2
3 k
2
4 k
2
10 a
2 µ4h (N
0
h)
2β2vh, and
α1 = 2k3k4k10k11a
2µ2hN
0
hN
0
vβvh [2k2(k10aµhβvh − k8δγh)− k3k4k10aµhβvh] .
Now we compute the discriminant ∆ := α21 − 4α2α0, to obtain:
∆ = −16k23k24k2k210k211δγha4µ4h(N0h)2(N0v )2β2vh (k10aµhβvh + k8k2) (k10aµhβvh − δγhk8) .
Equation (72) admits a real solution if and only if ∆ ≥ 0. This condition is equivalent to
ψ := k10aµhβvh − δγhk8 ≤ 0 (73)
Under condition (73), we conclude that α1 < 0. Thus, Eq. (72) admits exactly two positive
solutions which are given by
β± =
−α1 ±
√
∆
2α2
=
N0h
k3k4k10k11a2N0vβvh
{√
δγh(aµhβvhk10 + k2k8)±
√
(−k2ψ)
}2
Thus, condition d21 − 4d2d0 > 0 written in the terms of βhv is equivalent to
βhv < β− or βhv > β+.
and the inequalities (25) then follow.
Remark 3. Note that condition (25) is equivalent to condition (65). Therefore, Theorem 5 is
equivalent to Theorem 3.
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F Proof of Theorem 6
Considering the model (6) without disease–induced death in human, and applying the same
procedure as appendix 3, we obtain that the non-zero equilibria of the basic model (6) satisfy
the linear equation
(sΓE + k6ΓL)(p1λ
∗
h + p0) = 0,
where p1 = µbΛhk9 (k2aµhβvh + k3k8(µh + σ)) and p0 = −µhk3k4k8k9µbΛh
(R20,δ=0 − 1).
Clearly, p1 > 0 and p0 ≥ 0 whenever R0,δ=0 ≤ 1, so that λ∗h = −
p0
p1
≤ 0. Therefore,
the model (6) without disease–induced death in human, has no endemic equilibrium whenever
R0,δ=0 ≤ 1. The above result suggests the impossibility of backward bifurcation in the model
(6) without disease–induced death, since no endemic equilibrium exists when R0,δ=0 < 1 (and
backward bifurcation requires the presence of at least two endemic equilibria when R0,δ=0 <
1) [29, 56].
To completely rule out backward bifurcation in model (6), we use the direct Lyapunov
method to prove the global stability of the DFE. Define the positively-invariant and attracting
region
D1 =
{
(Sh, Eh, Ih, Rh, Sv, Ev, Iv, E, L, P ) ∈ D : Sh ≤ N0h ;Sv ≤ N0v
}
.
Consider the Lyapunov function
G = q1Eh + q2Ih + q3Ev + q4Iv,
where
q1 =
1
k3
; q3 =
τ1S
0
h
k3k8
k11
k9
, q2 =
τ1S
0
h
k3k8
k11ζ2S
0
v
k4k9
, q4 =
τ1S
0
h
k3k8
.
and we have set τ1 =
µhβhv
Λh
and τ2 =
µhβvh
Λh
. The derivative of G is given by
G˙ = q1E˙h + q2I˙h + q3E˙v + q4I˙v
= q1(λhSh − k3Eh) + q2(γhEh − k4Ih) + q3(λvSv − k9Ev) + q4(γvEv − k8Iv)
= q1τ1Sh(ηvEv + Iv)− q3k9Ev + q4γvEv − q4k8Iv + q3τ2Sv(ηhEh + Ih)− q1k3Eh + q2γhEh − q2k4Ih
= (q1τ1Shηv + q4γv − q3k9)Ev + (q1τ1Sh − q4k8)Iv + (q3τ2Svηh + q2γh − q1k3)Eh + (q3τ2Sv − q2k4)Ih
≤ (q1τ1S0hηv + q4γv − q3k9)Ev + (q1τ1S0h − q4k8)Iv + (q3τ2S0vηh + q2γh − q1k3)Eh + (q3ζ2S0v − q2k4)Ih,
since Sh ≤ S0h, Sv ≤ S0v in D1.
Replacing qi, i = 1, . . . , 4, by their value gives after straightforward simplifications
G˙ ≤ (R20,δ=0 − 1)Eh
We have G˙ ≤ 0 if R0,δ=0 ≤ 1, with G˙ = 0 if R0,δ=0 = 1 or Eh = 0. Whenever Eh = 0, we also
have Ih = 0, Ev = 0 and Iv = 0. Substituting Eh = Ih = Ev = Iv = 0 in the first, fourth and
fifth equation of Eq. (6) with δ = 0 gives Sh(t) → S0h = N0h , Rh(t)→ 0, and Sv(t)→ S0v = N0v
as t→∞. Thus
[Sh(t), Eh(t), Ih(t), Rh(t), Sv(t), Ev(t), Iv(t), E(t), L(t), P (t)] → (N0h , 0, 0, 0, N0v , 0, 0, E, L, P )
as t→∞.
It follows from the LaSalle’s invariance principle [32, 36, 37] that every solution of (6) (when
R0,δ=0 ≤ 1), with initial conditions in D1 converges to E1, as t → ∞. Hence, the DFE, E1, of
model (6) without disease–induced death, is GAS in D1 if R0,δ=0 ≤ 1.
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